Morphine
Other / unclassified targets OPRM1
Regulatory milestones approvals, filings & regulatory actions · 5 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansions (3) | US (FDA) | MORPHINE SULFATE | — | 2010-01-25 – 2021-06-02 | fda.gov ↗ |
| Label expansion | US (FDA) | ARYMO ER | — | 2018-10-12 | fda.gov ↗ |
| Approved | US (FDA) | DURAMORPH PF | — | 1984-09-18 | fda.gov ↗ |
Trials 310 · started per year
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 04 trials | ||||||
| Phase 0 | NCT05019638 | Mar 2021 → May 2028 expected | — | University of Utah | Active not recruiting | No outcome recorded |
| Phase 0 | NCT03926559 | Apr 2019 → May 2021 | — | Augusta University | Unknown | No outcome recorded |
| Phase 0 | NCT05037812 | Mar 2019 → Mar 2028 expected | — | University of Utah | Active not recruiting | No outcome recorded |
| Phase 0 | NCT02825056 | Jul 2016 → Jun 2017 | vascular disorder | Post Graduate Institute of Medical Education and Research, Chandigarh | Unknown | No outcome recorded |
| Phase 119 trials | ||||||
| Phase 1 | NCT05587998 | Aug 2022 → May 2023 | substance-related disorder | AstraZeneca | Completed | No outcome recorded |
| Phase 1 | NCT04448561 | Jun → Sep 2020 | substance-related disorder | Astellas Pharma Global Development, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT03801629 | Sep 2019 → Mar 2021 | — | Yale University | Completed | No outcome recorded |
| Phase 1 | NCT03425084 | Jun 2018 → Feb 2020 | — | University of Southern Denmark | Completed | No outcome recorded |
| Phase 1 | NCT02824276 | Jan 2017 → Dec 2022 | — | Brigham and Women's Hospital | Completed | No outcome recorded |
| Phase 1 | NCT02156596 | Feb 2013 → Dec 2017 | urinary tract obstruction | University of Monastir | Completed | No outcome recorded |
| Phase 1 | NCT01766960 | Nov 2012 → Mar 2014 | fatty liver disease | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| Phase 1 | NCT01476124 | Aug → Oct 2011 | restless legs syndrome | XenoPort, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00923000 | Dec 2008 → Dec 2009 | — | Tri-Service General Hospital (TSGH) | Unknown | No outcome recorded |
| Phase 1 | NCT00802308 | Dec 2008 → Feb 2009 | — | Egalet Ltd | Completed | No outcome recorded |
| Phase 1 | NCT00474799 | Jan → Feb 2007 | — | Javelin Pharmaceuticals | Completed | No outcome recorded |
| Phase 1 | NCT00759915 | Aug → Sep 2006 | — | Actavis Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00759902 | Aug → Sep 2006 | — | Actavis Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00768183 | May → Jul 2006 | — | Actavis Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00759759 | Sep 2004 | — | Actavis Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00759954 | Sep → Oct 2004 | — | Actavis Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00759356 | Aug → Sep 2004 | — | Actavis Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00125684 | Jul 2003 → Jul 2007 | cancer | Alberta Health services | Completed | No outcome recorded |
| Phase 1 | NCT00728832 | May 2002 → Feb 2003 | — | EKR Therapeutics, Inc | Completed | No outcome recorded |
| Phase 1/212 trials | ||||||
| Phase 1/2 | NCT06875791 | Dec 2025 → Dec 2026 expected | head and neck squamous cell carcinoma, mucositis | Fundacion Clinica Valle del Lili | Not yet recruiting | No outcome recorded |
| Phase 1/2 | NCT06065956 | Aug 2022 → Jun 2023 | — | Pakistan Navy Station Shifa Hospital | Completed | No outcome recorded |
| Phase 1/2 | NCT04427826 | Dec 2020 → Jun 2027 expected | chronic obstructive pulmonary disease | University Hospital, Grenoble | Recruiting | No outcome recorded |
| Phase 1/2 | NCT04138615 | Nov 2019 → Jan 2022 | — | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
| Phase 1/2 | NCT04160520 | Oct 2019 → Jan 2023 | urinary system disorder | East Carolina University | Completed | No outcome recorded |
| Phase 1/2 | NCT03035578 | Dec 2017 → Jun 2018 | — | The Hospital for Sick Children | Withdrawn | No outcome recorded |
| Phase 1/2 | NCT03015246 | Dec 2016 → Jun 2020 | heroin dependence | Wayne State University | Completed | No outcome recorded |
| Phase 1/2 | NCT01975753 | May 2014 → May 2018 | — | University Hospital, Rouen | Completed | No outcome recorded |
| Phase 1/2 | NCT01477190 | Oct 2010 → Oct 2011 | colon carcinoma, diverticulitis, inflammatory bowel disease | McGill University Health Centre/Research Institute of the McGill University Health Centre | Completed | No outcome recorded |
| Phase 1/2 | NCT01136356 | Jul 2010 → Mar 2012 | opiate dependence, opioid abuse | Johns Hopkins University | Completed | No outcome recorded |
| Phase 1/2 | NCT00244153 | Jun 2004 → Aug 2007 | rheumatic disorder | Charite University, Berlin, Germany | Unknown | No outcome recorded |
| Phase 1/2 | NCT00007254 | Mar 2000 → Feb 2003 | decubitus ulcer | University of Kansas | Completed | No outcome recorded |
| Phase 234 trials | ||||||
| Phase 2 | NCT07201987 | Jan 2027 → Jan 2028 expected | — | Ganesh M. Shankar | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT06837857 | Apr 2025 → Jul 2029 expected | chronic pain syndrome | Mayo Clinic | Recruiting | No outcome recorded |
| Phase 2 | NCT06716749 | Dec 2024 → May 2025 | osteoarthritis, knee | Carilion Clinic | Completed | No outcome recorded |
| Phase 2 | NCT05800834 | Sep 2023 → Mar 2024 | breast cancer, head and neck cancer | Brazilian National Cancer Institute | Unknown | No outcome recorded |
| Phase 2 | NCT05367336 | Aug 2022 → Feb 2025 | qualitative platelet defect | Corewell Health South | Terminated | No outcome recorded |
| Phase 2 | NCT05017246 | Jan 2022 → Jul 2024 | uterine corpus leiomyoma | Washington University School of Medicine | Terminated | No outcome recorded |
| Phase 2 | NCT05463367 | Jan 2021 → Jun 2025 overdue | chronic pain syndrome, opiate dependence, substance abuse | Northwestern University | Active not recruiting | No outcome recorded |
| Phase 2 | NCT05324995 | Jan 2021 → Feb 2022 | — | Isfahan University of Medical Sciences | Completed | No outcome recorded |
| Phase 2 | NCT04358133 | Dec 2020 → Oct 2022 | acute respiratory failure | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 2 | NCT04582786 | Dec 2020 → Jan 2022 | — | Alaxia SAS | Unknown | No outcome recorded |
| Phase 2 | NCT03824834 | Aug 2019 → Jun 2020 | chronic obstructive pulmonary disease, interstitial lung disease | Dennis Jensen, Ph.D. | Unknown | No outcome recorded |
| Phase 2 | NCT03034382 | Jan 2016 → May 2017 | rotator cuff syndrome | Assiut University | Unknown | No outcome recorded |
| Phase 2 | NCT02267304 | Oct 2013 → Aug 2016 | — | French National Institute of Health and Medical Research | Completed | No outcome recorded |
| Phase 2 | NCT01914042 | Jul 2013 → Jul 2019 | neuropathy, painful | Rambam Health Care Campus | Unknown | No outcome recorded |
| Phase 2 | NCT01878006 | Jun 2013 → Apr 2017 | heroin dependence | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Completed | No outcome recorded |
| Phase 2 | NCT01871285 | Jun 2013 → Jul 2014 | — | BioDelivery Sciences International | Completed | No outcome recorded |
| Phase 2 | NCT01738100 | Sep 2012 → Dec 2016 | ST-elevation myocardial infarction | Hyeon-Cheol Gwon | Unknown | No outcome recorded |
| Phase 2 | NCT01906762 | Jul 2012 → Feb 2013 | urinary system disorder | Seyed Mehdi Pourafzali | Completed | No outcome recorded |
| Phase 2 | NCT00818493 | Feb → Jul 2009 | — | QRxPharma Inc. | Completed | No outcome recorded |
| Phase 2 | NCT00678145 | Mar 2008 → Aug 2018 | autonomic nervous system disorder, hypoglycemia, type 1 diabetes mellitus | Albert Einstein College of Medicine | Terminated | No outcome recorded |
| Phase 2 | NCT00712712 | Dec 2007 → Feb 2016 | cancer of unknown primary site, metastatic malignant neoplasm | Institut Bergonié | Completed | No outcome recorded |
| Phase 2 | NCT00446069 | Aug 2007 → Jun 2008 | cancer | Egalet Ltd | Completed | No outcome recorded |
| Phase 2 | NCT00644319 | Mar 2007 → Sep 2009 | metastatic malignant neoplasm | Oxford University Hospitals NHS Trust | Unknown | No outcome recorded |
| Phase 2 | NCT00460239 | Jan 2007 → Jul 2009 | substance-related disorder | Johns Hopkins University | Completed | No outcome recorded |
| Phase 2 | NCT00494429 | May 2005 → Nov 2014 | — | John van den Anker | Completed | No outcome recorded |
| Phase 2 | NCT00142519 | Mar 2005 → Jul 2018 | — | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
| Phase 2 | NCT00142896 | Feb → Dec 2005 | opiate dependence | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
| Phase 2 | NCT00388011 | Jan → Aug 2005 | — | Javelin Pharmaceuticals | Completed | No outcome recorded |
| Phase 2 | NCT00390312 | Sep → Nov 2001 | — | Javelin Pharmaceuticals | Completed | No outcome recorded |
| Phase 2 | NCT00020618 | Mar 2001 → Feb 2004 | cancer of unknown primary site | Dana-Farber Cancer Institute | Completed | No outcome recorded |
| Phase 2 | NCT00009672 | Jan 2001 → Dec 2006 | radiculopathy, sciatica | National Institute of Dental and Craniofacial Research (NIDCR) | Completed | No outcome recorded |
| Phase 2 | NCT00383682 | Jul 1997 → Apr 2003 | chronic pain syndrome | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Completed | No outcome recorded |
| Phase 2 | NCT00000335 | Sep 1995 → Mar 1996 | substance-related disorder | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
| Phase 2 | NCT00000273 | Aug 1995 → Nov 2005 | heroin dependence | New York State Psychiatric Institute | Completed | No outcome recorded |
| Phase 2/36 trials | ||||||
| Phase 2/3 | NCT03407404 | Oct 2017 → Jun 2019 | — | Makerere University | Terminated | No outcome recorded |
| Phase 2/3 | NCT02967302 | Aug 2015 → Dec 2021 | osteoarthritis, knee | Hildrun Haibel | Unknown | No outcome recorded |
| Phase 2/3 | NCT03238430 | May 2015 → May 2019 | — | University Hospital, Lille | Completed | No outcome recorded |
| Phase 2/3 | NCT02030717 | Feb 2012 → May 2015 | renal cell carcinoma | Umeå University | Completed | No outcome recorded |
| Phase 2/3 | NCT01837446 | Jul 2011 → Jul 2012 | stomatitis | Isfahan University of Medical Sciences | Completed | No outcome recorded |
| Phase 2/3 | NCT00982891 | Mar 2010 → Jun 2012 | chronic obstructive pulmonary disease | Nova Scotia Health Authority | Completed | No outcome recorded |
| Phase 350 trials | ||||||
| Phase 3 | NCT06593665 | Sep 2024 → Dec 2026 expected | testicular cancer | Indiana University | Recruiting | No outcome recorded |
| Phase 3 | NCT06349668 | Apr 2024 → Oct 2027 expected | congenital anomaly of kidney and urinary tract, kidney benign neoplasm, kidney cancer, ureter benign neoplasm +3 | Hans Bahlmann | Recruiting | No outcome recorded |
| Phase 3 | NCT05236647 | Mar 2022 → Jan 2025 | — | University Hospital, Akershus | Completed | No outcome recorded |
| Phase 3 | NCT04429516 | Dec 2020 → Mar 2023 | idiopathic pulmonary fibrosis | Royal Brompton & Harefield NHS Foundation Trust | Completed | No outcome recorded |
| Phase 3 | NCT04188418 | Oct 2020 → Aug 2027 expected | cancer, hematopoietic and lymphoid cell neoplasm | M.D. Anderson Cancer Center | Active not recruiting | No outcome recorded |
| Phase 3 | NCT04455802 | Oct 2020 → May 2021 | neonatal abstinence syndrome | Women and Infants Hospital of Rhode Island | Withdrawn | No outcome recorded |
| Phase 3 | NCT04497831 | Sep 2020 → Sep 2022 | idiopathic pulmonary fibrosis | Medical University of Gdansk | Unknown | No outcome recorded |
| Phase 3 | NCT03948464 | Dec 2019 → Jun 2020 | substance-related disorder | M. Eugenia Socias | Terminated | No outcome recorded |
| Phase 3 | NCT03678792 | Nov 2019 → Sep 2020 | opiate dependence, substance withdrawal syndrome | University of Alabama at Birmingham | Withdrawn | No outcome recorded |
| Phase 3 | NCT03933397 | Aug 2019 → May 2022 | sickle cell disease | Duke University | Terminated | No outcome recorded |
| Phase 3 | NCT03618082 | Jun 2019 → May 2022 | — | University Hospital, Clermont-Ferrand | Unknown | No outcome recorded |
| Phase 3 | NCT03967327 | Apr 2019 → Dec 2020 | — | Mundipharma (China) Pharmaceutical Co. Ltd | Unknown | No outcome recorded |
| Phase 3 | NCT03537612 | Jun 2018 → Apr 2022 | scoliosis | Dr. Jean A. Ouellet, MD, FRCSC | Terminated | No outcome recorded |
| Phase 3 | NCT03580187 | Jun 2018 → Apr 2020 | — | University Hospital, Mahdia | Completed | No outcome recorded |
| Phase 3 | NCT03513445 | Jun 2018 → Mar 2022 | intervertebral disk degenerative disorder, lumbar disk disease, spondylolisthesis | University of Minnesota | Withdrawn | No outcome recorded |
| Phase 3 | NCT03586934 | Jun 2018 → Jun 2019 | substance-related disorder | Rush University Medical Center | Withdrawn | No outcome recorded |
| Phase 3 | NCT03429400 | Apr 2018 → May 2019 | — | West-Ward Pharmaceutical | Completed | No outcome recorded |
| Phase 3 | NCT03257319 | Sep 2017 → Jul 2022 | — | University Hospital, Rouen | Completed | No outcome recorded |
| Phase 3 | NCT02720822 | Aug 2016 → Dec 2019 | chronic obstructive pulmonary disease | Flinders University | Completed | No outcome recorded |
| Phase 3 | NCT03127800 | May 2016 → Nov 2017 | obstructive sleep apnea syndrome | Papworth Hospital NHS Foundation Trust | Terminated | No outcome recorded |
| Phase 3 | NCT02455362 | May 2015 → Dec 2017 | chronic obstructive pulmonary disease | Flinders University | Withdrawn | No outcome recorded |
| Phase 3 | NCT02591017 | Feb 2015 → Jul 2017 | — | University Hospital, Basel, Switzerland | Terminated | No outcome recorded |
| Phase 3 | NCT02868944 | Aug 2014 → Jan 2017 | — | Reims University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT02540070 | Aug 2014 → Dec 2017 | osteoarthritis, knee | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Unknown | No outcome recorded |
| Phase 3 | NCT02173756 | Jun 2014 → Sep 2017 | cancer | University Hospital, Strasbourg, France | Terminated | No outcome recorded |
| Phase 3 | NCT02028923 | Apr 2014 → Jul 2016 | chronic ulcer of skin | Institut Curie | Terminated | No outcome recorded |
| Phase 3 | NCT03263689 | Mar 2014 → Jun 2016 | — | Mbarara University of Science and Technology | Completed | No outcome recorded |
| Phase 3 | NCT01825993 | Apr 2013 → Apr 2015 | sigmoid neoplasm | Corporacion Parc Tauli | Unknown | No outcome recorded |
| Phase 3 | NCT01680939 | May 2012 → Dec 2013 | obstructive sleep apnea syndrome | Hamilton Health Sciences Corporation | Unknown | No outcome recorded |
| Phase 3 | NCT02264821 | Feb 2012 → Aug 2014 | — | Dr Madeleine Wilwerth | Completed | No outcome recorded |
| Phase 3 | NCT01186445 | Jan 2011 → Dec 2016 | acute myocardial infarction | French Cardiology Society | Completed | No outcome recorded |
| Phase 3 | NCT01280331 | Jan → Apr 2011 | — | QRxPharma Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01367418 | Sep 2010 → Mar 2012 | prostate cancer | Örebro University, Sweden | Completed | No outcome recorded |
| Phase 3 | NCT01123551 | Jun 2010 → Jul 2014 | — | University of Monastir | Completed | No outcome recorded |
| Phase 3 | NCT01055015 | Feb → Dec 2010 | — | QRxPharma Inc. | Completed | No outcome recorded |
| Phase 3 | NCT03365817 | Feb 2009 → Dec 2014 | chronic pain syndrome, substance-related disorder | Rigshospitalet, Denmark | Completed | No outcome recorded |
| Phase 3 | NCT00560183 | Nov 2007 → Apr 2008 | — | QRxPharma Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00737997 | Dec 2006 → Dec 2007 | scoliosis | The Hospital for Sick Children | Completed | No outcome recorded |
| Phase 3 | NCT00420992 | Dec 2006 → Nov 2007 | chronic pain syndrome, osteoarthritis | Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00415597 | Dec 2006 → Mar 2008 | — | Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00390039 | May → Sep 2006 | — | Javelin Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT00287326 | Jan → Jun 2006 | — | University of North Carolina, Chapel Hill | Terminated | No outcome recorded |
| Phase 3 | NCT00219921 | Sep 2005 → Feb 2007 | — | Rijnstate Hospital | Completed | No outcome recorded |
| Phase 3 | NCT00266539 | Apr 2004 → Apr 2005 | — | Alza Corporation | Completed | No outcome recorded |
| Phase 3 | NCT00264485 | Mar 2004 → Apr 2005 | — | Alza Corporation | Completed | No outcome recorded |
| Phase 3 | NCT00213200 | Jul 2003 → Jun 2005 | — | The Hospital for Sick Children | Completed | No outcome recorded |
| Phase 3 | NCT00201539 | Apr 2002 → Nov 2006 | cancer | Norwegian University of Science and Technology | Completed | No outcome recorded |
| Phase 3 | NCT00003687 | Jun 1998 → Sep 2001 | cancer of unknown primary site, leukemia, myelodysplastic syndrome, myeloproliferative neoplasm +3 | NCIC Clinical Trials Group | Completed | No outcome recorded |
| Phase 3 | NCT00004390 | Feb 1995 → ? | postherpetic neuralgia | National Center for Research Resources (NCRR) | Completed | No outcome recorded |
| Phase 3 | NCT00410540 | ? → May 2001 | — | Alza Corporation | Completed | No outcome recorded |
| Phase 499 trials | ||||||
| Phase 4 | NCT07560501 | Apr → Dec 2026 expected | — | Tribhuvan University Teaching Hospital, Institute Of Medicine. | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07288528 | Apr 2026 → Apr 2029 expected | hypersensitivity reaction disease | McMaster University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07377630 | Mar 2026 → Mar 2027 expected | pregnancy disorder | Gaslini Institute | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07472959 | Feb → May 2026 overdue | cardiac valvular defect | Istanbul University - Cerrahpasa | Recruiting | No outcome recorded |
| Phase 4 | NCT06797973 | Jul 2025 → May 2027 expected | — | Anne Juul Wikkelsø | Recruiting | No outcome recorded |
| Phase 4 | NCT06935708 | Apr 2025 → Oct 2026 expected | colorectal carcinoma | Meri Mirceta | Recruiting | No outcome recorded |
| Phase 4 | NCT06881563 | Mar 2025 → Jul 2026 overdue | colorectal cancer | Meri Mirceta | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06666985 | Dec 2024 → Jun 2026 overdue | — | First Affiliated Hospital, Sun Yat-Sen University | Recruiting | No outcome recorded |
| Phase 4 | NCT06511232 | Aug 2024 → Jul 2027 expected | — | The Methodist Hospital Research Institute | Recruiting | No outcome recorded |
| Phase 4 | NCT07386353 | May 2024 → Jul 2026 overdue | — | Hospital Central do Funchal | Recruiting | No outcome recorded |
| Phase 4 | NCT05905367 | Jan 2024 → Dec 2025 | substance-related disorder | Pouya Azar | Completed | No outcome recorded |
| Phase 4 | NCT07008443 | Jan 2024 → Apr 2025 | — | Alzahraa Ahmed Abbas | Completed | No outcome recorded |
| Phase 4 | NCT06113497 | Nov 2023 → Oct 2024 | — | Kyunghee University Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT05920642 | Sep 2023 → Jul 2025 | — | University Hospital Ostrava | Completed | No outcome recorded |
| Phase 4 | NCT05742958 | Jun → Sep 2023 | — | Cukurova University | Unknown | No outcome recorded |
| Phase 4 | NCT05722002 | Feb 2023 → Dec 2026 expected | neuropathy, painful | University of Michigan | Recruiting | No outcome recorded |
| Phase 4 | NCT07516717 | Jan 2023 → Jun 2024 | — | Hospital Universitario de Caracas | Completed | No outcome recorded |
| Phase 4 | NCT04527393 | May 2022 → Jan 2024 | — | Children's Hospital of Fudan University | Completed | No outcome recorded |
| Phase 4 | NCT05217160 | May 2021 → May 2022 overdue | — | The Metis Foundation | Recruiting | No outcome recorded |
| Phase 4 | NCT04755712 | Mar 2021 → Oct 2022 | — | Ramsay Santé | Completed | No outcome recorded |
| Phase 4 | NCT04752033 | Mar 2021 → Feb 2023 | — | Mayo Clinic | Completed | No outcome recorded |
| Phase 4 | NCT05281081 | Jan → Aug 2021 | — | Sohag University | Completed | No outcome recorded |
| Phase 4 | NCT05659823 | Nov 2020 → Nov 2021 | — | Conrad Arnfinn Bjørshol | Completed | No outcome recorded |
| Phase 4 | NCT04298853 | Jun 2020 → Oct 2021 | neonatal abstinence syndrome | Indiana University | Completed | No outcome recorded |
| Phase 4 | NCT04388111 | May 2020 → Apr 2021 | arthropathy | The Methodist Hospital Research Institute | Completed | No outcome recorded |
| Phase 4 | NCT04017442 | Oct 2019 → Aug 2023 | postpartum depression, pregnancy disorder | Icahn School of Medicine at Mount Sinai | Completed | No outcome recorded |
| Phase 4 | NCT05259098 | Oct 2019 → Jun 2020 | chronic pain syndrome | Hospital Central do Funchal | Completed | No outcome recorded |
| Phase 4 | NCT03843281 | May 2019 → Oct 2020 | — | Bruno Minotti | Completed | No outcome recorded |
| Phase 4 | NCT03853694 | Mar 2019 → Jan 2020 | — | Pacira Pharmaceuticals, Inc | Completed | No outcome recorded |
| Phase 4 | NCT03761277 | Jan 2019 → Dec 2021 | bone pain, periodic, chronic pain syndrome, neuropathy, painful | MedtronicNeuro | Completed | No outcome recorded |
| Phase 4 | NCT03693404 | Dec 2018 → Jun 2021 | — | NYU Langone Health | Completed | No outcome recorded |
| Phase 4 | NCT04342130 | Apr 2018 → Apr 2019 | chronic pain syndrome | University of Rochester | Completed | No outcome recorded |
| Phase 4 | NCT03451695 | Apr 2018 → Dec 2020 | chronic pain syndrome | B.P. Koirala Institute of Health Sciences | Completed | No outcome recorded |
| Phase 4 | NCT03386630 | Mar 2018 → Jun 2019 | — | Fundación Pública Andaluza Progreso y Salud | Completed | No outcome recorded |
| Phase 4 | NCT03434951 | Nov 2017 → Sep 2019 | neuropathy, painful | South Carelia Central Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT03007121 | Apr 2017 → Dec 2018 | — | Charles University, Czech Republic | Completed | No outcome recorded |
| Phase 4 | NCT03875274 | Apr → Dec 2017 | — | B.P. Koirala Institute of Health Sciences | Completed | No outcome recorded |
| Phase 4 | NCT02929147 | Nov 2016 → Nov 2017 | supratentorial cancer | Istanbul University | Unknown | No outcome recorded |
| Phase 4 | NCT03013075 | Nov 2016 → Dec 2017 | — | Post Graduate Institute of Medical Education and Research, Chandigarh | Unknown | No outcome recorded |
| Phase 4 | NCT02967172 | Oct 2016 → Sep 2018 | ankle defects short stature, neuropathy, painful | University of Iowa | Completed | No outcome recorded |
| Phase 4 | NCT02741076 | Sep 2016 → Apr 2018 | opiate dependence, opioid abuse | Member Companies of the Opioid PMR Consortium | Terminated | No outcome recorded |
| Phase 4 | NCT02924974 | Sep 2016 → May 2018 | prostate disorder | Maasstad Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02734940 | Jul 2016 → Feb 2017 | heart disorder | Virginia Commonwealth University | Terminated | No outcome recorded |
| Phase 4 | NCT03675646 | Mar 2016 → Jun 2017 | neuropathy, painful | Charles University, Czech Republic | Completed | No outcome recorded |
| Phase 4 | NCT02848729 | Feb → Mar 2016 | — | Mallinckrodt | Completed | No outcome recorded |
| Phase 4 | NCT02641301 | Dec 2015 → Dec 2016 | — | Hopital Lariboisière | Unknown | No outcome recorded |
| Phase 4 | NCT02627950 | Dec 2015 → Oct 2018 | acute myocardial infarction | University of Luebeck | Completed | No outcome recorded |
| Phase 4 | NCT02530151 | Nov 2015 → May 2017 | — | Northwestern University | Completed | No outcome recorded |
| Phase 4 | NCT02600715 | Nov 2015 → Jun 2017 | interstitial cystitis, overactive bladder | Edgar LeClaire, MD | Completed | No outcome recorded |
| Phase 4 | NCT02869321 | May 2015 → May 2018 | upper aerodigestive tract neoplasm | Central Hospital, Nancy, France | Completed | No outcome recorded |
| Phase 4 | NCT02793947 | May 2015 → Aug 2016 | neuropathy, painful | University of Iowa | Completed | No outcome recorded |
| Phase 4 | NCT02101554 | Apr 2015 → Jun 2019 | — | Pfizer | Terminated | No outcome recorded |
| Phase 4 | NCT02913469 | Dec 2014 → Aug 2020 | ST-elevation myocardial infarction | General Hospital of Chinese Armed Police Forces | Unknown | No outcome recorded |
| Phase 4 | NCT02279628 | Jul 2014 → Dec 2016 | — | Central Hospital, Nancy, France | Unknown | No outcome recorded |
| Phase 4 | NCT02026687 | Mar 2014 → Apr 2016 | female reproductive organ cancer | Lena Nilsson | Completed | No outcome recorded |
| Phase 4 | NCT01898052 | Oct 2012 → Feb 2014 | — | Thammasat University | Completed | No outcome recorded |
| Phase 4 | NCT01667445 | Sep 2012 → Sep 2014 | osteoarthritis | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Completed | No outcome recorded |
| Phase 4 | NCT01536964 | Apr 2012 → Mar 2013 | cardiovascular disorder | Sheffield Teaching Hospitals NHS Foundation Trust | Completed | No outcome recorded |
| Phase 4 | NCT02046772 | Mar 2012 → Mar 2014 | hemorrhoid | Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias | Completed | No outcome recorded |
| Phase 4 | NCT01566253 | Mar → Dec 2012 | — | University Hospital, Montpellier | Completed | No outcome recorded |
| Phase 4 | NCT01509638 | Mar → Oct 2012 | — | Pacira Pharmaceuticals, Inc | Completed | No outcome recorded |
| Phase 4 | NCT02677532 | Dec 2011 → Nov 2013 | — | University of Genova | Completed | No outcome recorded |
| Phase 4 | NCT01465984 | Nov 2011 → Sep 2012 | — | Tehran University of Medical Sciences | Completed | No outcome recorded |
| Phase 4 | NCT01465191 | Nov 2011 → May 2014 | — | Columbia University | Completed | No outcome recorded |
| Phase 4 | NCT01322360 | Apr 2011 → Apr 2012 | — | Roxane Laboratories | Completed | No outcome recorded |
| Phase 4 | NCT01304212 | Apr 2011 → Feb 2014 | — | Jose Antonio Bernia Gil | Completed | No outcome recorded |
| Phase 4 | NCT02467556 | Mar 2011 → May 2014 | complex regional pain syndrome type 1 | Helsinki University Central Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02620631 | Mar 2011 → Feb 2014 | — | Stony Brook University | Unknown | No outcome recorded |
| Phase 4 | NCT01422291 | Jan → Jul 2011 | — | Pamukkale University | Completed | No outcome recorded |
| Phase 4 | NCT01318187 | Jan → Mar 2011 | urolithiasis | Pamukkale University | Completed | No outcome recorded |
| Phase 4 | NCT01560767 | Oct 2010 → Jul 2011 | osteoarthritis, knee | University of Warwick | Completed | No outcome recorded |
| Phase 4 | NCT01312077 | Oct 2010 → Jun 2011 | — | Cork University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT01245244 | Oct 2010 → Sep 2012 | pain agnosia | University of Aarhus | Completed | No outcome recorded |
| Phase 4 | NCT01211431 | Sep 2010 → Oct 2012 | — | Nîmes University Hospital | Withdrawn | No outcome recorded |
| Phase 4 | NCT01234272 | Aug 2010 → Jan 2011 | gastric cancer | Yonsei University | Completed | No outcome recorded |
| Phase 4 | NCT01179191 | Aug 2010 → Apr 2011 | — | Pfizer | Terminated | No outcome recorded |
| Phase 4 | NCT01312415 | Aug 2010 → Jun 2011 | — | Cork University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT01079754 | Mar 2010 → Dec 2011 | — | Mahidol University | Unknown | No outcome recorded |
| Phase 4 | NCT00934661 | Jan 2010 → Mar 2013 | — | Wake Forest University | Terminated | No outcome recorded |
| Phase 4 | NCT00895531 | Dec 2009 → Dec 2012 | osteoarthritis, knee | University of Louisville | Terminated | No outcome recorded |
| Phase 4 | NCT00878371 | May 2009 → Feb 2013 | thoracic aortic aneurysm | Nova Scotia Health Authority | Completed | No outcome recorded |
| Phase 4 | NCT00880607 | Dec 2008 → Apr 2011 | scoliosis | University of Colorado, Denver | Completed | No outcome recorded |
| Phase 4 | NCT00783016 | Oct 2008 → Feb 2011 | appendicitis | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT00737737 | Aug 2008 → Sep 2013 | chronic pain syndrome, osteoarthritis | National Institute of Nursing Research (NINR) | Completed | No outcome recorded |
| Phase 4 | NCT00681174 | Jul 2008 → Nov 2010 | — | University of Parma | Terminated | No outcome recorded |
| Phase 4 | NCT00901628 | Apr 2008 → Mar 2009 | osteoarthritis, knee | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01322191 | Apr 2008 → Nov 2010 | — | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Completed | No outcome recorded |
| Phase 4 | NCT00640042 | Mar → Nov 2008 | — | Pfizer | Completed | No outcome recorded |
| Phase 4 | NCT00562627 | Nov 2007 → Jun 2009 | osteoarthritis, knee | Asker & Baerum Hospital | Completed | No outcome recorded |
| Phase 4 | NCT00772187 | Oct 2007 → Sep 2009 | pain agnosia | Rambam Health Care Campus | Completed | No outcome recorded |
| Phase 4 | NCT00270322 | Jan 2006 → Mar 2007 | neuropathy, painful, osteoarthritis | Rambam Health Care Campus | Terminated | No outcome recorded |
| Phase 4 | NCT00155376 | Sep 2005 | liver disorder | National Taiwan University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT00155233 | Jan 2005 → ? | — | National Taiwan University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT00158873 | Sep 2004 → ? | — | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 4 | NCT00477061 | Jan 2004 → Mar 2005 | appendicitis | Tehran University of Medical Sciences | Completed | No outcome recorded |
| Phase 4 | NCT00378937 | Jan 2004 → Feb 2006 | cancer of unknown primary site | University Hospitals Bristol and Weston NHS Foundation Trust | Completed | No outcome recorded |
| Phase 4 | NCT00803114 | Mar 2002 → Nov 2004 | — | Mount Sinai Hospital, Canada | Completed | No outcome recorded |
| Phase 4 | NCT01112540 | — | — | Akdeniz University | Completed | No outcome recorded |
| Phase 4 | NCT00231517 | — | epidermolysis bullosa | Institute of Child Health | Completed | No outcome recorded |
| Phase not applicable86 trials | ||||||
| — | NCT07231926 | Dec 2025 → Jun 2026 overdue | — | Ataturk University | Recruiting | No outcome recorded |
| — | NCT07232108 | Dec 2025 → Jun 2026 overdue | — | Ataturk University | Recruiting | No outcome recorded |
| — | NCT07201272 | Oct 2025 → Apr 2026 | — | Tanta University | Completed | No outcome recorded |
| — | NCT07126483 | Aug 2025 → Jan 2026 | — | Ondokuz Mayıs University | Completed | No outcome recorded |
| — | NCT07023679 | Jun 2025 → Jun 2029 expected | acute myocardial infarction | The Second Hospital of Anhui Medical University | Recruiting | No outcome recorded |
| — | NCT06990893 | Jun 2025 → Oct 2026 expected | — | Anqing Municipal Hospital | Recruiting | No outcome recorded |
| — | NCT06947135 | May 2025 → Jun 2026 overdue | acute myocardial infarction | The Second Hospital of Anhui Medical University | Recruiting | No outcome recorded |
| — | NCT06837506 | Feb → Aug 2025 overdue | — | Ain Shams University | Recruiting | No outcome recorded |
| — | NCT06820190 | Feb 2025 → Dec 2026 expected | idiopathic scoliosis | Tanta University | Recruiting | No outcome recorded |
| — | NCT06761989 | Jan 2025 → Dec 2026 expected | — | Seoul National University Hospital | Recruiting | No outcome recorded |
| — | NCT06409689 | Jun 2024 → Jun 2025 overdue | — | Tongji Hospital | Recruiting | No outcome recorded |
| — | NCT06240390 | May → Aug 2024 | neuropathy, painful | Universidad Europea de Canarias | Withdrawn | No outcome recorded |
| — | NCT06331143 | Mar 2024 → Jan 2026 | idiopathic scoliosis | Tanta University | Completed | No outcome recorded |
| — | NCT05908851 | Nov 2023 → Nov 2024 | — | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Unknown | No outcome recorded |
| — | NCT07023497 | Jul 2023 → Jul 2026 overdue | — | University of Ioannina | Recruiting | No outcome recorded |
| — | NCT07012590 | May 2023 → Jul 2024 | — | Kafrelsheikh University | Completed | No outcome recorded |
| — | NCT06681805 | Jan 2023 → Sep 2024 | — | Kafrelsheikh University | Completed | No outcome recorded |
| — | NCT05738759 | May 2022 → Jul 2024 | lumbar disk disease | Queen Savang Vadhana Memorial Hospital, Thailand | Unknown | No outcome recorded |
| — | NCT06630520 | Mar → Jun 2022 | — | Taipei Veterans General Hospital, Taiwan | Completed | No outcome recorded |
| — | NCT05322603 | Mar → Aug 2022 | — | Petrovsky National Research Centre of Surgery | Completed | No outcome recorded |
| — | NCT05117034 | Feb 2022 → May 2025 overdue | neuropathy, painful | Tel-Aviv Sourasky Medical Center | Active not recruiting | No outcome recorded |
| — | NCT04672382 | Jul 2021 → May 2022 | — | Aalborg University | Completed | No outcome recorded |
| — | NCT04729049 | Feb 2021 → Jun 2022 | spondylolisthesis, vertebral column disorder | AUSL Romagna Rimini | Completed | No outcome recorded |
| — | NCT04700007 | Jan → Dec 2021 | — | Aalborg University | Completed | No outcome recorded |
| — | NCT04445636 | Jun → Dec 2020 | — | Cairo University | Completed | No outcome recorded |
| — | NCT04402411 | Jun → Sep 2020 | urinary bladder cancer | National Cancer Institute, Egypt | Unknown | No outcome recorded |
| — | NCT05331781 | Jan 2020 → Jan 2021 | — | Sohag University | Completed | No outcome recorded |
| — | NCT05393414 | Nov 2019 → Mar 2020 | — | University of Puerto Rico | Completed | No outcome recorded |
| — | NCT04079673 | Oct 2019 → Sep 2021 | — | National Taiwan University Hospital | Completed | No outcome recorded |
| — | NCT03715517 | Oct 2018 → Jul 2031 expected | liver cancer | University of Manitoba | Recruiting | No outcome recorded |
| — | NCT03664622 | Sep 2018 → Dec 2019 | — | Cairo University | Completed | No outcome recorded |
| — | NCT05379374 | Aug 2018 → Jan 2020 | — | B.P. Koirala Institute of Health Sciences | Completed | No outcome recorded |
| — | NCT03379987 | Jan 2018 → Jul 2019 | — | Assiut University | Unknown | No outcome recorded |
| — | NCT03365115 | Jan 2018 → Jan 2019 | osteoarthritis, knee | Keimyung University Dongsan Medical Center | Unknown | No outcome recorded |
| — | NCT03232957 | Aug 2017 → Feb 2019 | osteoarthritis, knee | Mahidol University | Completed | No outcome recorded |
| — | NCT05248724 | Aug 2017 → Sep 2020 | — | Castilla-La Mancha Health Service | Completed | No outcome recorded |
| — | NCT03518463 | Jun → Jul 2017 | pregnancy disorder | Mbarara University of Science and Technology | Completed | No outcome recorded |
| — | NCT02990910 | Nov 2016 → Feb 2017 | — | Children's Hospital of Fudan University | Completed | No outcome recorded |
| — | NCT02880800 | Aug 2016 → Aug 2017 | neuropathy, painful | Mount Sinai Hospital, Canada | Unknown | No outcome recorded |
| — | NCT05853263 | Mar 2016 → Jul 2020 | congenital heart disease | Erasmus Medical Center | Completed | No outcome recorded |
| — | NCT02801838 | Feb 2016 → Feb 2017 | — | Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil | Completed | No outcome recorded |
| — | NCT02605187 | Nov 2015 → May 2017 | — | Stanford University | Completed | No outcome recorded |
| — | NCT02531165 | Sep 2015 → Feb 2018 | acute myocardial infarction | Centre Hospitalier Universitaire Vaudois | Completed | No outcome recorded |
| — | NCT02469077 | Aug 2015 → Sep 2019 | chronic pain syndrome | Vanderbilt University Medical Center | Completed | No outcome recorded |
| — | NCT02440399 | Jul 2015 → May 2017 | — | HaEmek Medical Center, Israel | Completed | No outcome recorded |
| — | NCT03010540 | Jul 2015 → Nov 2016 | subacute delirium | Post Graduate Institute of Medical Education and Research, Chandigarh | Completed | No outcome recorded |
| — | NCT02458742 | Jun 2015 → Aug 2016 | — | Mahidol University | Completed | No outcome recorded |
| — | NCT02430818 | Apr 2015 → Sep 2017 | — | Washington University School of Medicine | Terminated | No outcome recorded |
| — | NCT01984463 | Feb → May 2014 | — | University of Montreal Hospital Centre (CHUM) | Terminated | No outcome recorded |
| — | NCT01991275 | Nov 2013 → Jun 2014 | prostate neoplasm | Seoul National University Hospital | Completed | No outcome recorded |
| — | NCT01997788 | Aug → Oct 2013 | renal cell carcinoma | Seoul National University Hospital | Completed | No outcome recorded |
| — | NCT02064894 | Jul 2013 → Jun 2015 | musculoskeletal system disorder | St. Justine's Hospital | Completed | No outcome recorded |
| — | NCT01794689 | May 2013 → Jan 2018 | — | Johns Hopkins University | Completed | No outcome recorded |
| — | NCT01690780 | Sep 2012 → Feb 2014 | — | Naveen Poonai | Completed | No outcome recorded |
| — | NCT01917045 | Jan 2012 → Mar 2013 | — | Peking University First Hospital | Completed | No outcome recorded |
| — | NCT01511627 | Jan → Jul 2012 | — | University of Saskatchewan | Withdrawn | No outcome recorded |
| — | NCT01977898 | Nov 2011 → Mar 2019 | cerebrospinal fluid leak, headache disorder | Northwestern University | Completed | No outcome recorded |
| — | NCT01296334 | Feb → Sep 2011 | — | mads u werner | Completed | No outcome recorded |
| — | NCT00955877 | Mar 2010 → Jan 2015 | spastic cerebral palsy | Washington University School of Medicine | Terminated | No outcome recorded |
| — | NCT01749826 | Jan 2010 → Jul 2013 | — | Stanford University | Terminated | No outcome recorded |
| — | NCT00874172 | Oct 2009 → Oct 2012 | sickle cell disease | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| — | NCT05831761 | Sep 2009 → Oct 2011 | — | University Medical Centre Ljubljana | Completed | No outcome recorded |
| — | NCT00910208 | Apr 2009 → Jun 2010 | — | Albert Einstein College of Medicine | Completed | No outcome recorded |
| — | NCT00849719 | Apr 2009 → Apr 2010 | — | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| — | NCT00726830 | Mar 2009 → Sep 2010 | cancer of unknown primary site, central nervous system neoplasm, leukemia, lymphoproliferative syndrome +5 | M.D. Anderson Cancer Center | Terminated | No outcome recorded |
| — | NCT01602640 | Jan 2009 → Feb 2012 | respiratory failure | Clínica de Los Andes IPS | Completed | No outcome recorded |
| — | NCT00839787 | Dec 2008 → Dec 2009 | — | University of Texas Southwestern Medical Center | Withdrawn | No outcome recorded |
| — | NCT01541124 | Aug 2008 → Jun 2011 | chronic pain syndrome | Federal University of São Paulo | Completed | No outcome recorded |
| — | NCT00456638 | Apr 2008 | — | Drexel University College of Medicine | Withdrawn | No outcome recorded |
| — | NCT00553553 | Sep 2007 → May 2008 | liver disorder | St Vincent's University Hospital, Ireland | Unknown | No outcome recorded |
| — | NCT01366313 | Sep 2007 → Mar 2011 | — | Procare Riaya Hospital | Completed | No outcome recorded |
| — | NCT00504283 | Feb → Oct 2007 | nephrolithiasis | Dartmouth-Hitchcock Medical Center | Completed | No outcome recorded |
| — | NCT00994539 | Jan → Feb 2007 | — | Roxane Laboratories | Completed | No outcome recorded |
| — | NCT00994383 | Jan 2007 | — | Roxane Laboratories | Completed | No outcome recorded |
| — | NCT00335517 | Jun 2006 → Sep 2010 | — | University of Rochester | Completed | No outcome recorded |
| — | NCT00306020 | Jan 2006 → Jun 2012 | ulcer disease | Soroka University Medical Center | Withdrawn | No outcome recorded |
| — | NCT00256347 | Mar 2005 → Dec 2006 | — | University of California, San Francisco | Completed | No outcome recorded |
| — | NCT00293969 | Mar 2005 → Jan 2006 | — | Montefiore Medical Center | Completed | No outcome recorded |
| — | NCT00184938 | Jan 2005 → ? | ischemic disease | Radboud University Medical Center | Suspended | No outcome recorded |
| — | NCT00199316 | Jan → Nov 2005 | — | Khon Kaen University | Unknown | No outcome recorded |
| — | NCT00487084 | Aug 2004 → Sep 2008 | — | Northwestern University | Completed | No outcome recorded |
| — | NCT00636415 | Jun 2004 → Jul 2005 | — | Federal University of São Paulo | Completed | No outcome recorded |
| — | NCT00200590 | Dec 2003 → Jul 2006 | — | Nantes University Hospital | Terminated | No outcome recorded |
| — | NCT00695045 | Jul 2003 → Jan 2007 | neuropathy, painful, osteoarthritis, knee | University College Hospital Galway | Completed | No outcome recorded |
| — | NCT01513564 | Jan 2001 → Dec 2003 | spondylolisthesis | Northern Orthopaedic Division, Denmark | Completed | No outcome recorded |
| — | NCT00004696 | Aug 1994 → Jul 1998 | — | Seattle Children's Hospital | Completed | No outcome recorded |
Also used as a comparator or background therapy in 731 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 016 trials | ||||||
| Phase 0 | NCT06854211 Comparator | Jul 2026 → Jan 2027 expected | obstructive sleep apnea syndrome, substance-related disorder | Brigham and Women's Hospital | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT06617949 Comparator | Jan 2025 → Dec 2027 expected | substance-related disorder | Medical College of Wisconsin | Recruiting | No outcome recorded |
| Phase 0 | NCT06621849 Comparator | Sep 2024 → May 2025 | neuropathy, painful | Cairo University | Completed | No outcome recorded |
| Phase 0 | NCT06387303 Comparator | Aug 2024 → May 2026 overdue | — | University of Virginia | Recruiting | No outcome recorded |
| Phase 0 | NCT05150756 Comparator | Jan → Jul 2022 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 0 | NCT04859803 Comparator | Jun 2021 → Sep 2023 | — | Cairo University | Completed | No outcome recorded |
| Phase 0 | NCT04648540 Comparator | Dec 2020 → Aug 2022 | — | Cairo University | Completed | No outcome recorded |
| Phase 0 | NCT04279054 Comparator | Sep 2020 → Jul 2023 | — | University of Alabama at Birmingham | Completed | No outcome recorded |
| Phase 0 | NCT03579446 Background | Nov 2018 → Jun 2023 | hematopoietic and lymphoid cell neoplasm, metastatic malignant neoplasm | M.D. Anderson Cancer Center | Terminated | No outcome recorded |
| Phase 0 | NCT03525509 Comparator | Jun 2018 → Aug 2019 | — | simon.haroutounian | Completed | No outcome recorded |
| Phase 0 | NCT03473093 Comparator | Mar 2018 → Mar 2019 | — | Assiut University | Unknown | No outcome recorded |
| Phase 0 | NCT03427463 Comparator | Jan 2018 → Aug 2023 | — | Medical University of South Carolina | Completed | No outcome recorded |
| Phase 0 | NCT02369523 Comparator | Sep 2014 → Apr 2017 | — | University of Utah | Terminated | No outcome recorded |
| Phase 0 | NCT01866254 Comparator | May 2013 → Dec 2017 | — | Grace Shih, MD | Completed | No outcome recorded |
| Phase 0 | NCT01705288 Comparator | Jan 2013 → Aug 2016 | cervical cancer, endometrial cancer, ovarian cancer | Masonic Cancer Center, University of Minnesota | Completed | No outcome recorded |
| Phase 0 | NCT02152410 Comparator | Apr 2012 → Apr 2013 | — | University of Monastir | Completed | No outcome recorded |
| Phase 120 trials | ||||||
| Phase 1 | NCT06882369 Comparator | Nov 2024 → Jun 2025 overdue | — | Minia University | Active not recruiting | No outcome recorded |
| Phase 1 | NCT06653244 Comparator | Apr → Dec 2024 | — | Menoufia University | Completed | No outcome recorded |
| Phase 1 | NCT06192589 Comparator | Feb → Sep 2024 | drug-induced liver injury | Food and Drug Administration (FDA) | Completed | No outcome recorded |
| Phase 1 | NCT05251376 Background | Feb → Dec 2022 | opiate dependence | Lyndra Inc. | Withdrawn | No outcome recorded |
| Phase 1 | NCT05143424 Comparator | Nov 2021 → Sep 2023 | substance-related disorder | National Institute on Drug Abuse (NIDA) | Unknown | No outcome recorded |
| Phase 1 | NCT04009759 Comparator | Oct 2021 → Jan 2025 | cardiac arrest | University Hospital, Akershus | Unknown | No outcome recorded |
| Phase 1 | NCT04030442 Comparator | May 2019 → Jan 2025 | chronic pain syndrome | Wayne State University | Unknown | No outcome recorded |
| Phase 1 | NCT04330547 Comparator | Feb 2018 → Feb 2019 | akinetic mutism, brain injury | University of Liege | Completed | No outcome recorded |
| Phase 1 | NCT03017248 Background | Jan → Jun 2016 | — | Faculty of Medicine, Sousse | Unknown | No outcome recorded |
| Phase 1 | NCT02033707 Background | Apr 2014 → Feb 2019 | — | Johns Hopkins University | Completed | No outcome recorded |
| Phase 1 | NCT02078089 Background | Mar → Dec 2014 | cancer | Costantine Albany | Terminated | No outcome recorded |
| Phase 1 | NCT02014714 Comparator | Dec 2013 → Jun 2014 | obstructive sleep apnea syndrome | University of Malaya | Unknown | No outcome recorded |
| Phase 1 | NCT02083315 Comparator | Jul → Aug 2013 | — | Trevena Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01671410 Comparator | Aug 2012 → Sep 2016 | neonatal abstinence syndrome | Thomas Jefferson University | Completed | No outcome recorded |
| Phase 1 | NCT01533155 Comparator | Mar → Sep 2012 | constipation disorder | AstraZeneca | Completed | No outcome recorded |
| Phase 1 | NCT01380093 Comparator | Feb → May 2011 | opioid abuse | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01595867 Comparator | Aug 2010 → Jan 2011 | chronic pain syndrome, opioid abuse | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01084473 Comparator | Mar → Jun 2010 | — | University of Turku | Completed | No outcome recorded |
| Phase 1 | NCT01119222 Comparator | Jul → Oct 2008 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT00521248 Comparator | Apr 2004 → Jan 2010 | neonatal abstinence syndrome | Thomas Jefferson University | Completed | No outcome recorded |
| Phase 1/210 trials | ||||||
| Phase 1/2 | NCT05257941 Comparator | Jan 2022 → Aug 2024 | — | Indiana University | Terminated | No outcome recorded |
| Phase 1/2 | NCT05037539 Comparator | Jun → Dec 2021 | bone pain, periodic | Department of Medical Services Ministry of Public Health of Thailand | Completed | No outcome recorded |
| Phase 1/2 | NCT04033471 Comparator | Jul 2019 → Mar 2021 | — | Assiut University | Unknown | No outcome recorded |
| Phase 1/2 | NCT03024957 Comparator | Jan 2017 → Sep 2018 | immunodeficiency disease | Assiut University | Unknown | No outcome recorded |
| Phase 1/2 | NCT02935933 Comparator | Oct 2016 → Sep 2017 | chronic pain syndrome | Assiut University | Unknown | No outcome recorded |
| Phase 1/2 | NCT01094522 Comparator | Mar 2010 → Jun 2012 | — | Stanford University | Completed | No outcome recorded |
| Phase 1/2 | NCT00672347 Comparator | Jul → Sep 2008 | — | Federal University of Minas Gerais | Completed | No outcome recorded |
| Phase 1/2 | NCT00751478 Comparator | Mar → May 2007 | — | Pfizer | Completed | No outcome recorded |
| Phase 1/2 | NCT00374881 Comparator | Sep 2006 → Jun 2007 | — | BioLineRx, Ltd. | Completed | No outcome recorded |
| Phase 1/2 | NCT00196131 Comparator | Jan 2005 → Apr 2008 | subarachnoid hemorrhage, traumatic brain injury | Dalhousie University | Unknown | No outcome recorded |
| Phase 271 trials | ||||||
| Phase 2 | NCT07657468 Background | Jun → Oct 2026 expected | — | National University of La Rioja | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07533786 Comparator | May → Nov 2026 expected | — | Haisco Pharmaceutical Group Co., Ltd. | Recruiting | No outcome recorded |
| Phase 2 | NCT07551739 Comparator | Apr → Nov 2026 expected | — | Haisco Pharmaceutical Group Co., Ltd. | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07491146 Comparator | Mar → Oct 2026 expected | — | Yingyong Zhou,MD,PhD | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT06985290 Comparator | Jul 2025 → Sep 2027 expected | brain hypoxia - ischemia | Ipsita Goswami | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT06901830 Comparator | May → Dec 2025 | — | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT07442877 Comparator | Sep 2024 → Jan 2025 | — | Haisco Pharmaceutical Group Co., Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT05006079 Comparator | Mar 2024 → Dec 2026 expected | opioid abuse | Wayne State University | Recruiting | No outcome recorded |
| Phase 2 | NCT06417268 Comparator | Mar 2024 → Sep 2025 | — | Kasr El Aini Hospital | Completed | No outcome recorded |
| Phase 2 | NCT06467409 Comparator | Jan 2024 → Jan 2025 | neuropathy, painful | Luye Pharma Group Ltd. | Unknown | No outcome recorded |
| Phase 2 | NCT06680466 Comparator | Dec 2023 → Jul 2024 | — | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT06204120 Comparator | Nov 2022 → Jul 2023 | neuropathy, painful | Luye Pharma Group Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT04772222 Comparator | Jun 2022 → Jan 2025 | brain hypoxia - ischemia | University of Utah | Completed | No outcome recorded |
| Phase 2 | NCT04291599 Comparator | Mar 2022 → Jul 2025 | acute pancreatitis | Boston Children's Hospital | Terminated | No outcome recorded |
| Phase 2 | NCT04061330 Comparator | Jan → Dec 2022 | — | The University of Texas Health Science Center, Houston | Withdrawn | No outcome recorded |
| Phase 2 | NCT03564548 Comparator | May 2021 → Mar 2022 | cancer | Tetra Bio-Pharma | Unknown | No outcome recorded |
| Phase 2 | NCT05186454 Comparator | May 2021 → Feb 2022 | — | Sohag University | Unknown | No outcome recorded |
| Phase 2 | NCT04104646 Comparator | Dec 2020 → Dec 2021 | neonatal abstinence syndrome | Chiesi Farmaceutici S.p.A. | Terminated | No outcome recorded |
| Phase 2 | NCT04589429 Comparator | Oct 2020 → Mar 2021 | — | Minia University | Unknown | No outcome recorded |
| Phase 2 | NCT04221165 Comparator | Aug 2020 → Sep 2023 | head and neck cancer, mucositis | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Completed | No outcome recorded |
| Phase 2 | NCT04243954 Comparator | Apr → Oct 2020 | — | Fujian Cancer Hospital | Completed | No outcome recorded |
| Phase 2 | NCT03968146 Background | Jun → Nov 2019 | idiopathic scoliosis | Kasr El Aini Hospital | Completed | No outcome recorded |
| Phase 2 | NCT03383588 Comparator | Jul → Aug 2018 | myofascial pain syndrome | Montefiore Medical Center | Terminated | No outcome recorded |
| Phase 2 | NCT03483870 Comparator | Jun 2018 → Oct 2020 | — | Assiut University | Completed | No outcome recorded |
| Phase 2 | NCT03433976 Background | May 2018 → May 2020 | — | University Hospital, Montpellier | Unknown | No outcome recorded |
| Phase 2 | NCT03393117 Background | Mar 2018 → Jul 2020 | breast cancer | Case Comprehensive Cancer Center | Withdrawn | No outcome recorded |
| Phase 2 | NCT03428633 Comparator | Mar 2018 → Feb 2021 | — | Asklepieion Voulas General Hospital | Completed | No outcome recorded |
| Phase 2 | NCT03256487 Comparator | Sep 2017 → Feb 2018 | — | Alameda Health System | Unknown | No outcome recorded |
| Phase 2 | NCT03254459 Comparator | Sep → Nov 2017 | — | INSYS Therapeutics Inc | Completed | No outcome recorded |
| Phase 2 | NCT03088826 Comparator | Aug 2017 → Dec 2020 | — | Antonios Likourezos | Completed | No outcome recorded |
| Phase 2 | NCT03401476 Comparator | May 2017 → Dec 2018 | pulmonary arterial hypertension | John Granton | Unknown | No outcome recorded |
| Phase 2 | NCT03275012 Background | Apr 2017 → Oct 2019 | chronic pain syndrome | Pharmaceutical Research Management srl | Withdrawn | No outcome recorded |
| Phase 2 | NCT03134703 Comparator | Feb 2017 → Mar 2019 | neonatal abstinence syndrome | Johns Hopkins All Children's Hospital | Terminated | No outcome recorded |
| Phase 2 | NCT03023982 Background | Feb 2017 → Feb 2019 | — | Soroka University Medical Center | Unknown | No outcome recorded |
| Phase 2 | NCT02804022 Background | Dec 2016 → May 2017 overdue | respiratory underresponsiveness to hypoxia and hypercapnia | KK Women's and Children's Hospital | Active not recruiting | No outcome recorded |
| Phase 2 | NCT02848599 Comparator | Jul 2016 → Jul 2017 | subjective cognitive decline | Osijek University Hospital | Completed | No outcome recorded |
| Phase 2 | NCT02716129 Comparator | Jul 2016 → Oct 2017 | — | Abdelrady S Ibrahim, MD | Completed | No outcome recorded |
| Phase 2 | NCT03005548 Background | Jun 2016 → Dec 2017 | neuropathy, painful | Military Medical Academy, Belgrade, Serbia | Completed | No outcome recorded |
| Phase 2 | NCT03036384 Background | Mar → Nov 2016 | — | Centre Hospitalier Universitaire Saint Pierre | Completed | No outcome recorded |
| Phase 2 | NCT02622126 Comparator | Jan → Jul 2016 | blood coagulation disease | Assiut University | Completed | No outcome recorded |
| Phase 2 | NCT02511483 Background | May 2015 → Nov 2016 | — | McGill University Health Centre/Research Institute of the McGill University Health Centre | Terminated | No outcome recorded |
| Phase 2 | NCT02462577 Comparator | Jan → Aug 2015 | chronic pain syndrome | Assiut University | Completed | No outcome recorded |
| Phase 2 | NCT02335294 Comparator | Dec 2014 → Jul 2015 | — | Trevena Inc. | Completed | No outcome recorded |
| Phase 2 | NCT02252926 Background | Sep 2014 → Dec 2015 | mucositis | Hvidovre University Hospital | Completed | No outcome recorded |
| Phase 2 | NCT02096003 Comparator | May 2014 → May 2017 | — | Icahn School of Medicine at Mount Sinai | Completed | No outcome recorded |
| Phase 2 | NCT02100748 Comparator | Apr → Oct 2014 | — | Trevena Inc. | Completed | No outcome recorded |
| Phase 2 | NCT02044302 Background | Apr 2014 → Jan 2016 | — | Yale University | Terminated | No outcome recorded |
| Phase 2 | NCT02860949 Background | Apr 2014 → Apr 2015 | osteoarthritis, knee | Thammasat University | Completed | No outcome recorded |
| Phase 2 | NCT03607916 Background | Feb → Aug 2014 | — | Centre Hospitalier Universitaire Saint Pierre | Completed | No outcome recorded |
| Phase 2 | NCT01932554 Background | Nov 2013 → Mar 2015 | sickle cell disease | St. Louis University | Withdrawn | No outcome recorded |
| Phase 2 | NCT04635852 Comparator | Mar 2013 → Nov 2014 | cancer | University of Cologne | Completed | No outcome recorded |
| Phase 2 | NCT01708707 Comparator | Dec 2012 → Oct 2017 | neonatal abstinence syndrome | Pediatrix | Completed | No outcome recorded |
| Phase 2 | NCT01691690 Background | Oct 2012 → Nov 2015 | tonsillitis | Nationwide Children's Hospital | Completed | No outcome recorded |
| Phase 2 | NCT01686802 Comparator | Sep 2012 → Sep 2016 | — | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Completed | No outcome recorded |
| Phase 2 | NCT02460913 Comparator | Apr 2012 → Mar 2013 | — | University of Monastir | Completed | No outcome recorded |
| Phase 2 | NCT02571491 Background | Jan 2012 → Feb 2014 | idiopathic scoliosis | Fundació Sant Joan de Déu | Completed | No outcome recorded |
| Phase 2 | NCT01084161 Comparator | Mar 2010 → Jan 2011 | — | Alkermes, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT00943566 Comparator | Jan → Dec 2010 | chronic pain syndrome | Labtec GmbH | Withdrawn | No outcome recorded |
| Phase 2 | NCT01038609 Comparator | Dec 2009 → May 2010 | — | AbbVie | Completed | No outcome recorded |
| Phase 2 | NCT00878293 Comparator | Apr 2009 → May 2010 | diabetic polyneuropathy | Tris Pharma, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT00872885 Comparator | Mar → Aug 2009 | — | Tris Pharma, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT00831051 Comparator | Dec 2008 → Jan 2009 | — | QRxPharma Inc. | Completed | No outcome recorded |
| Phase 2 | NCT01838707 Comparator | Dec 2007 → Mar 2013 | — | Assiut University | Completed | No outcome recorded |
| Phase 2 | NCT00558870 Comparator | Nov 2007 → Jan 2015 | — | M.D. Anderson Cancer Center | Terminated | No outcome recorded |
| Phase 2 | NCT00573937 Comparator | Aug 2007 → Apr 2009 | neoplasm | Mayo Clinic | Terminated | No outcome recorded |
| Phase 2 | NCT00782951 Comparator | Jul → Aug 2007 | — | Merck Sharp & Dohme LLC | Terminated | No outcome recorded |
| Phase 2 | NCT00488969 Comparator | Jul 2007 → Jul 2013 | neuropathy, painful, spinal cord injury | Icahn School of Medicine at Mount Sinai | Completed | No outcome recorded |
| Phase 2 | NCT00349401 Background | Dec 2006 → ? | — | Wake Forest University Health Sciences | Withdrawn | No outcome recorded |
| Phase 2 | NCT01242644 Comparator | Oct 2006 → Oct 2009 | — | University of South Alabama | Completed | No outcome recorded |
| Phase 2 | NCT00195910 Comparator | Oct 2004 → Jan 2005 | — | Montefiore Medical Center | Completed | No outcome recorded |
| Phase 2 | NCT02137525 Comparator | ? → Jun 2017 | — | INSYS Therapeutics Inc | Withdrawn | No outcome recorded |
| Phase 2/327 trials | ||||||
| Phase 2/3 | NCT06344169 Comparator | May 2024 → Mar 2026 overdue | chronic pain syndrome | Dalin Tzu Chi General Hospital | Recruiting | No outcome recorded |
| Phase 2/3 | NCT05375305 Comparator | May 2022 → Oct 2023 | — | Jiangsu HengRui Medicine Co., Ltd. | Completed | No outcome recorded |
| Phase 2/3 | NCT04794738 Comparator | Apr → Oct 2021 | — | Jiangsu HengRui Medicine Co., Ltd. | Unknown | No outcome recorded |
| Phase 2/3 | NCT04011163 Background | Mar 2021 → Dec 2025 overdue | respiratory underresponsiveness to hypoxia and hypercapnia | KK Women's and Children's Hospital | Active not recruiting | No outcome recorded |
| Phase 2/3 | NCT04589494 Comparator | Apr 2020 → Feb 2021 | chronic pain syndrome | Assiut University | Unknown | No outcome recorded |
| Phase 2/3 | NCT04301336 Background | Nov 2019 → Nov 2020 | sickle cell disease | Beni-Suef University | Completed | No outcome recorded |
| Phase 2/3 | NCT03730714 Comparator | Nov 2018 → Aug 2020 | — | Assiut University | Completed | No outcome recorded |
| Phase 2/3 | NCT03413059 Comparator | Feb → Jul 2018 | — | Assiut University | Unknown | No outcome recorded |
| Phase 2/3 | NCT02976597 Comparator | Nov 2016 → Jun 2018 | — | Assiut University | Completed | No outcome recorded |
| Phase 2/3 | NCT03936205 Background | Aug 2016 → Oct 2017 | metastatic malignant neoplasm | Hotel Dieu de France Hospital | Completed | No outcome recorded |
| Phase 2/3 | NCT03098420 Comparator | Jul 2016 → May 2021 | — | University of Alabama at Birmingham | Terminated | No outcome recorded |
| Phase 2/3 | NCT02811991 Comparator | Jun 2016 → Sep 2018 | — | Jiangsu HengRui Medicine Co., Ltd. | Completed | No outcome recorded |
| Phase 2/3 | NCT02731430 Comparator | Dec 2015 → Mar 2016 | — | Assiut University | Unknown | No outcome recorded |
| Phase 2/3 | NCT02726828 Comparator | Oct 2015 → Feb 2016 | — | Assiut University | Completed | No outcome recorded |
| Phase 2/3 | NCT02151682 Comparator | Apr 2015 → Oct 2017 | — | Grünenthal GmbH | Completed | No outcome recorded |
| Phase 2/3 | NCT02213159 Comparator | Jul 2014 → Nov 2015 | diabetes mellitus, hypertensive disorder, obesity disorder, sleep apnea syndrome | American University of Beirut Medical Center | Completed | No outcome recorded |
| Phase 2/3 | NCT02449954 Comparator | Jun 2014 → Apr 2015 | breast cancer | Assiut University | Unknown | No outcome recorded |
| Phase 2/3 | NCT02435537 Comparator | May 2013 → Mar 2015 | — | Assiut University | Completed | No outcome recorded |
| Phase 2/3 | NCT01807429 Comparator | Dec 2012 → Jan 2013 | dwarfism thin bones multiple fractures | Isfahan University of Medical Sciences | Completed | No outcome recorded |
| Phase 2/3 | NCT01508455 Background | Mar → May 2012 | — | Pfizer | Completed | No outcome recorded |
| Phase 2/3 | NCT01275547 Comparator | Jan → Jun 2011 | spinal stenosis | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
| Phase 2/3 | NCT01071057 Comparator | Dec 2010 → Apr 2013 | — | University of British Columbia | Completed | No outcome recorded |
| Phase 2/3 | NCT01159262 Background | Jul 2010 → Aug 2011 | — | Pfizer | Completed | No outcome recorded |
| Phase 2/3 | NCT01071499 Comparator | Mar 2010 → Nov 2012 | — | University of British Columbia | Completed | No outcome recorded |
| Phase 2/3 | NCT01249872 Comparator | Jan 2010 → Aug 2012 | morbid obesity | University of Patras | Completed | No outcome recorded |
| Phase 2/3 | NCT01021696 Comparator | Nov 2009 → Jul 2010 | dementia | University of Bergen | Completed | No outcome recorded |
| Phase 2/3 | NCT00305058 Comparator | Jul 2005 → Mar 2007 | — | Montefiore Medical Center | Completed | No outcome recorded |
| Phase 3103 trials | ||||||
| Phase 3 | NCT06940570 Comparator | Jan 2028 → Aug 2029 | aplastic anemia, bone marrow failure syndrome, leukemia, severe combined immunodeficiency | University of Texas Southwestern Medical Center | Suspended | No outcome recorded |
| Phase 3 | NCT07296770 Background | Oct 2026 → Dec 2027 expected | chronic pain syndrome | University of California, San Francisco | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06835504 Comparator | Sep 2026 → Aug 2029 expected | — | Columbia University | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07076641 Background | Jul 2026 → Jul 2027 expected | digestive system disorder | Ramsay Santé | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07445737 Comparator | Jun 2026 → Jun 2029 expected | ST-elevation myocardial infarction | Assistance Publique - Hôpitaux de Paris | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06315920 Comparator | May 2026 → May 2028 expected | sickle cell disease | Oman Medical Speciality Board | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07414706 Background | Mar 2026 → Jun 2028 expected | local anesthetic poisoning | Centre Hospitalier Universitaire, Amiens | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07149077 Background | Jan 2026 → Oct 2027 expected | — | University Hospital, Bordeaux | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07299630 Background | Dec 2025 → May 2026 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 3 | NCT07186426 Comparator | Jul 2025 → Mar 2026 overdue | — | Haisco Pharmaceutical Group Co., Ltd. | Recruiting | No outcome recorded |
| Phase 3 | NCT07050277 Comparator | Jun 2025 → Jul 2027 expected | osteoarthritis, knee, peripheral nerve lesion, urinary tract obstruction | University of Toronto | Recruiting | No outcome recorded |
| Phase 3 | NCT06890533 Comparator | May 2025 → Apr 2026 overdue | — | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Active not recruiting | No outcome recorded |
| Phase 3 | NCT06464146 Comparator | Feb 2025 → Feb 2028 expected | — | Assistance Publique - Hôpitaux de Paris | Recruiting | No outcome recorded |
| Phase 3 | NCT07666178 Comparator | Dec 2024 → Dec 2027 expected | — | Instituto do Coracao | Recruiting | No outcome recorded |
| Phase 3 | NCT06949852 Comparator | Aug 2024 → Jul 2025 | — | Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd | Completed | No outcome recorded |
| Phase 3 | NCT06319859 Comparator | Aug 2024 → Oct 2025 | neuropathy, painful | Cairo University | Completed | No outcome recorded |
| Phase 3 | NCT06160778 Comparator | May 2024 → Jan 2029 expected | appendicitis | University of Calgary | Recruiting | No outcome recorded |
| Phase 3 | NCT06381063 Background | Mar 2024 → Mar 2027 expected | — | Centre Hospitalier Universitaire, Amiens | Recruiting | No outcome recorded |
| Phase 3 | NCT06728371 Comparator | Mar → Dec 2024 overdue | neuropathy, painful | Chinese University of Hong Kong | Recruiting | No outcome recorded |
| Phase 3 | NCT05913284 Comparator | Jan 2024 → Feb 2026 overdue | chronic pain syndrome, neuropathy, painful | Chinese University of Hong Kong | Active not recruiting | No outcome recorded |
| Phase 3 | NCT05831449 Background | May 2023 → Sep 2025 | toe, misshapen | Cali Pharmaceuticals LLC | Completed | No outcome recorded |
| Phase 3 | NCT05813847 Background | Apr 2023 → Sep 2025 | — | Cali Pharmaceuticals LLC | Completed | No outcome recorded |
| Phase 3 | NCT05324358 Comparator | Dec 2022 → Sep 2024 | — | Neumentum, Inc. | Suspended | No outcome recorded |
| Phase 3 | NCT05325164 Comparator | Sep 2022 → Aug 2023 | adenocarcinoma | Ottawa Hospital Research Institute | Withdrawn | No outcome recorded |
| Phase 3 | NCT05515809 Comparator | Jul 2022 → Jun 2025 overdue | — | Centre Hospitalier Universitaire, Amiens | Active not recruiting | No outcome recorded |
| Phase 3 | NCT05887258 Comparator | May 2022 → May 2024 | — | Unai Ortega Mera | Completed | No outcome recorded |
| Phase 3 | NCT05630222 Comparator | Mar 2022 → Feb 2023 | — | Isfahan University of Medical Sciences | Completed | No outcome recorded |
| Phase 3 | NCT05099055 Comparator | Mar 2022 → Jan 2023 | — | St. Justine's Hospital | Completed | No outcome recorded |
| Phase 3 | NCT00362219 Comparator | Jan 2022 → Dec 2023 | — | Rambam Health Care Campus | Withdrawn | No outcome recorded |
| Phase 3 | NCT05137184 Comparator | Nov 2021 → Apr 2023 | — | Oslo University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT04886453 Comparator | Aug 2021 → Mar 2024 | — | Centre Hospitalier Universitaire Dijon | Completed | No outcome recorded |
| Phase 3 | NCT04785768 Comparator | Jul 2021 → May 2024 | — | Fujian Cancer Hospital | Completed | No outcome recorded |
| Phase 3 | NCT04852003 Comparator | May → Jun 2021 | — | Jiangsu HengRui Medicine Co., Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT04528563 Comparator | May 2021 → Feb 2023 | appendicitis | Hamilton Health Sciences Corporation | Completed | No outcome recorded |
| Phase 3 | NCT04766463 Comparator | Mar → Oct 2021 | — | Jiangsu HengRui Medicine Co., Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT05163366 Comparator | Mar → Nov 2021 | — | Mbarara University of Science and Technology | Completed | No outcome recorded |
| Phase 3 | NCT04688814 Comparator | Dec 2020 → Dec 2021 | neuralgia, neuropathy, painful | Alexandria University | Completed | No outcome recorded |
| Phase 3 | NCT04214834 Comparator | Sep 2020 → Jan 2024 overdue | neonatal abstinence syndrome | Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program | Active not recruiting | No outcome recorded |
| Phase 3 | NCT04533243 Comparator | Sep 2020 → Aug 2022 | — | Fujian Cancer Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT04476173 Comparator | Jun 2020 → Jun 2024 | ST-elevation myocardial infarction, acute coronary syndrome | Collegium Medicum w Bydgoszczy | Unknown | No outcome recorded |
| Phase 3 | NCT04256642 Comparator | Feb 2020 → Jan 2022 | — | McGill University Health Centre/Research Institute of the McGill University Health Centre | Unknown | No outcome recorded |
| Phase 3 | NCT03511833 Comparator | Dec 2019 → Dec 2021 | — | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| Phase 3 | NCT04013958 Comparator | Aug 2019 → Aug 2021 | urinary tract obstruction | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| Phase 3 | NCT03825198 Comparator | Aug 2019 → Dec 2023 | neuropathy, painful, peripheral nerve lesion | Dr M. B. Breebaart | Unknown | No outcome recorded |
| Phase 3 | NCT03751423 Comparator | Jun 2019 → Dec 2023 | — | Dr. Marie Eve Sophie Bussiere-Cote | Suspended | No outcome recorded |
| Phase 3 | NCT03823534 Background | Feb 2019 → Dec 2026 expected | bone neoplasm, plasma cell myeloma, substance-related disorder | St. Louis University | Recruiting | No outcome recorded |
| Phase 3 | NCT03639389 Comparator | Jan 2019 → Mar 2022 | — | Karolinska Institutet | Completed | No outcome recorded |
| Phase 3 | NCT03774836 Comparator | Dec 2018 → May 2019 overdue | — | Avenue Therapeutics, Inc. | Active not recruiting | No outcome recorded |
| Phase 3 | NCT03585374 Comparator | Feb 2018 → Feb 2019 | — | Mundipharma Pharmaceuticals srl | Completed | No outcome recorded |
| Phase 3 | NCT03825887 Comparator | Feb 2018 → Dec 2020 | acute myeloid leukemia | Children's Cancer Hospital Egypt 57357 | Completed | No outcome recorded |
| Phase 3 | NCT03396588 Comparator | Dec 2017 → Apr 2024 | neonatal abstinence syndrome | Henrietta Bada | Completed | No outcome recorded |
| Phase 3 | NCT03236805 Comparator | Nov 2017 → Nov 2022 | — | Nantes University Hospital | Terminated | No outcome recorded |
| Phase 3 | NCT03261193 Background | Sep 2017 → Jun 2018 | neuropathy, painful | Nicholas Schott | Terminated | No outcome recorded |
| Phase 3 | NCT03063359 Comparator | May 2017 → Jul 2018 | — | University Hospital, Montpellier | Terminated | No outcome recorded |
| Phase 3 | NCT01906073 Comparator | Jan 2017 → Dec 2020 | cancer | Norwegian University of Science and Technology | Withdrawn | No outcome recorded |
| Phase 3 | NCT01994967 Background | Nov → Dec 2016 | vertebral column disorder | Cristália Produtos Químicos Farmacêuticos Ltda. | Withdrawn | No outcome recorded |
| Phase 3 | NCT02749409 Comparator | Aug 2016 → Jul 2018 | — | Chang Gung Memorial Hospital | Terminated | No outcome recorded |
| Phase 3 | NCT02820324 Comparator | May → Dec 2016 | — | Trevena Inc. | Completed | No outcome recorded |
| Phase 3 | NCT02815709 Comparator | May → Dec 2016 | — | Trevena Inc. | Completed | No outcome recorded |
| Phase 3 | NCT02880540 Comparator | Mar 2016 → Feb 2018 | obesity disorder | Janelle Vaughns | Completed | No outcome recorded |
| Phase 3 | NCT02558010 Background | Feb 2016 → Jan 2022 | scoliosis | Medical College of Wisconsin | Completed | No outcome recorded |
| Phase 3 | NCT02687347 Comparator | Feb 2016 → Feb 2018 | neurological pain disorder | McGill University Health Centre/Research Institute of the McGill University Health Centre | Unknown | No outcome recorded |
| Phase 3 | NCT02698995 Comparator | Nov 2015 → Feb 2017 | — | Foisor Orthopedics Clinical Hospital | Completed | No outcome recorded |
| Phase 3 | NCT02749162 Comparator | Nov 2015 → Feb 2017 | — | Foisor Orthopedics Clinical Hospital | Completed | No outcome recorded |
| Phase 3 | NCT04482192 Comparator | Jun 2015 → Jan 2020 | — | Zagazig University | Completed | No outcome recorded |
| Phase 3 | NCT02954484 Comparator | Apr 2015 → May 2017 | neuropathy, painful | National University Hospital, Singapore | Completed | No outcome recorded |
| Phase 3 | NCT02410317 Comparator | Feb 2015 → Aug 2021 | — | University Hospital, Grenoble | Completed | No outcome recorded |
| Phase 3 | NCT02292667 Background | Jan 2015 → Dec 2018 | abdominal aortic aneurysm | Centre Hospitalier Universitaire de Besancon | Unknown | No outcome recorded |
| Phase 3 | NCT02781415 Comparator | Jul 2014 → Jul 2015 | urinary tract obstruction | University of Monastir | Completed | No outcome recorded |
| Phase 3 | NCT01718496 Comparator | Jul 2014 → Aug 2016 | chronic obstructive pulmonary disease | McGill University Health Centre/Research Institute of the McGill University Health Centre | Unknown | No outcome recorded |
| Phase 3 | NCT02473198 Background | Jan 2014 → Feb 2017 | osteoarthritis | The New England Baptist Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT02145975 Comparator | Jan → Apr 2014 | — | Universidad de Antioquia | Completed | No outcome recorded |
| Phase 3 | NCT01958476 Comparator | Sep 2013 → Mar 2017 | neonatal abstinence syndrome | Tufts Medical Center | Completed | No outcome recorded |
| Phase 3 | NCT02277678 Comparator | Aug 2013 → Dec 2014 | — | KK Women's and Children's Hospital | Completed | No outcome recorded |
| Phase 3 | NCT01872728 Comparator | Jun → Dec 2013 | — | Hospices Civils de Lyon | Unknown | No outcome recorded |
| Phase 3 | NCT01539538 Comparator | Apr → Dec 2012 | — | Talphera, Inc | Completed | No outcome recorded |
| Phase 3 | NCT01549002 Comparator | Jan 2012 → Apr 2013 | abscess | Columbia University | Completed | No outcome recorded |
| Phase 3 | NCT01522534 Comparator | Jan 2012 → Dec 2013 | — | Centre Hospitalier Annecy Genevois | Terminated | No outcome recorded |
| Phase 3 | NCT01452789 Comparator | Nov 2011 → Jun 2016 | neonatal abstinence syndrome | Thomas Jefferson University | Completed | No outcome recorded |
| Phase 3 | NCT01318161 Comparator | Mar 2011 → Dec 2020 | colorectal cancer | Örebro University, Sweden | Terminated | No outcome recorded |
| Phase 3 | NCT01675622 Comparator | Jan 2011 → Jun 2012 | cancer | Mundipharma (China) Pharmaceutical Co. Ltd | Completed | No outcome recorded |
| Phase 3 | NCT01380197 Comparator | May 2010 → Jan 2014 | sickle cell disease | Children's Healthcare of Atlanta | Completed | No outcome recorded |
| Phase 3 | NCT01304134 Comparator | Mar → Aug 2010 | — | Mundipharma (China) Pharmaceutical Co. Ltd | Completed | No outcome recorded |
| Phase 3 | NCT01077752 Background | Feb 2010 → Jun 2012 | neuropathy, painful | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 3 | NCT00875550 Comparator | Jan 2010 → Jan 2011 | — | Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT01016808 Comparator | Dec 2009 → Mar 2010 | — | QRxPharma Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00848419 Comparator | Apr → Dec 2009 | — | Hadassah Medical Organization | Withdrawn | No outcome recorded |
| Phase 3 | NCT04887649 Comparator | Mar 2009 → Apr 2010 | — | National University of Colombia | Completed | No outcome recorded |
| Phase 3 | NCT00820027 Background | Dec 2008 → Dec 2010 | neuropathy, painful | Organon and Co | Completed | No outcome recorded |
| Phase 3 | NCT00784472 Comparator | Dec 2008 → Jun 2012 | urolithiasis | Katja venborg Pedersen | Completed | No outcome recorded |
| Phase 3 | NCT00822614 Comparator | Dec 2008 → Dec 2009 | — | Akela Pharma, Inc. | Unknown | No outcome recorded |
| Phase 3 | NCT00803283 Comparator | Nov → Dec 2008 | — | Johnson & Johnson Taiwan Ltd | Terminated | No outcome recorded |
| Phase 3 | NCT00701909 Comparator | Jun 2008 → Apr 2009 | — | University of California, San Francisco | Completed | No outcome recorded |
| Phase 3 | NCT00634010 Comparator | Feb 2008 → Jan 2015 | cancer | M.D. Anderson Cancer Center | Terminated | No outcome recorded |
| Phase 3 | NCT00656773 Comparator | Jan → Sep 2008 | — | University Hospital, Toulouse | Completed | No outcome recorded |
| Phase 3 | NCT00609466 Comparator | Sep 2007 → Feb 2008 | — | Grünenthal GmbH | Completed | No outcome recorded |
| Phase 3 | NCT00472303 Comparator | Jul 2007 → Jun 2012 | neoplasm | Grünenthal GmbH | Completed | No outcome recorded |
| Phase 3 | NCT00505414 Comparator | Jun 2007 → Feb 2009 | cancer | Grünenthal GmbH | Terminated | No outcome recorded |
| Phase 3 | NCT00478023 Comparator | May 2007 → Feb 2008 | — | Grünenthal GmbH | Completed | No outcome recorded |
| Phase 3 | NCT00416039 Background | Jan 2007 → Nov 2008 | — | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 3 | NCT01079117 Comparator | Oct 2006 → Jun 2011 | opiate dependence | Mundipharma Medical Company | Completed | No outcome recorded |
| Phase 3 | NCT01082471 Comparator | Nov 2005 → Nov 2006 | — | Paion UK Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT02810782 Comparator | Jun 2001 → Dec 2007 | neonatal abstinence syndrome | University of Zurich | Completed | No outcome recorded |
| Phase 4255 trials | ||||||
| Phase 4 | NCT07624006 Comparator | Jan 2027 → Feb 2030 expected | — | University Hospital, Strasbourg, France | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07229495 Comparator | Jul 2026 → Jun 2027 expected | adolescent idiopathic scoliosis | Peking Union Medical College Hospital | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07525986 Comparator | Apr 2026 → Mar 2027 expected | — | Peking University First Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT07423650 Background | Mar → Oct 2026 expected | — | Iuliu Hatieganu University of Medicine and Pharmacy | Recruiting | No outcome recorded |
| Phase 4 | NCT07412223 Comparator | Feb → Dec 2026 expected | ileus, neuropathy, painful | Xiangya Hospital of Central South University | Not yet recruiting | No outcome recorded |
| Show all 255 trials opens the full record — a long page | ||||||
| Phase not applicable229 trials | ||||||
| — | NCT06727435 Background | Aug 2026 → Apr 2028 expected | — | Beijing Tiantan Hospital | Not yet recruiting | No outcome recorded |
| — | NCT07712783 Background | Jul → Sep 2026 expected | — | Ondokuz Mayıs University | Not yet recruiting | No outcome recorded |
| — | NCT07658521 Background | Jul → Dec 2026 expected | — | Ain Shams University | Enrolling by invitation | No outcome recorded |
| — | NCT07695935 Comparator | Jun → Oct 2026 expected | — | Hitit University | Recruiting | No outcome recorded |
| — | NCT07584200 Comparator | Jun 2026 → Mar 2027 expected | osteoarthritis, hip | Poznan University of Medical Sciences | Not yet recruiting | No outcome recorded |
| Show all 229 trials opens the full record — a long page | ||||||
Evidence & citations 62 cited values
Every value below carries the sentence it was read from. 1,050 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Morphine | “The current double-blind, placebo-controlled in-patient study was designed to compare the effects of intravenously delivered fentanyl (0, 0.0625, 0.125, 0.187, and 0.250 mg/70...” PMID 17581533 ↗ Jun 2007945“All patients will be submitted to the institution's standard management: multimodal analgesia with common analgesic (dipyrone 4 to 8 g / day or paracetamol 1500 to 2250 mg /...” NCT07666178 ↗ “The tradition standard protocols involve the use of 0.3mg/kg of oral morphine about an hour before the start of the procedure before the start of the procedure to allow for the...” NCT05163366 ↗ “Postoperative patient controlled epidural analgesia (epidural cathterer inserted into Th7-8 intervertebral space, 200 ml of 0.125% levobupivacaine, 4 mg of morphine, 0.075 mg...” NCT05831761 ↗ “Intravenous morphine bolus doses of 2.5 mg or 5 mg may be administered for breakthrough pain when CPOT remains greater than 1 or when the treating clinician judges that pain is...” NCT06727435 ↗ “Intraoperative time: intravenous ketamine 0.5 mg kg-1, intravenous dexamethasone 8 mg Postoperative time: paracetamol 1 g every 6 hours a day, nefopam 20 every 8 hours a day,...” NCT06381063 ↗ “Injection Cocktail includes: 10mg Morphine, 30mg Ketorolac, 3.5ug/ml (385ug total) of Ropivicaine, 2.5ug /ml (275ug total) Epinephrine with the remainder of the solution made...” NCT01667445 ↗ “Tramadol 50mg IV bolus was firstly administered to the patients and if the NRS scale was not decreased at least about 2 points after 30 minutes, morphine 2mg IV was then...” NCT01526525 ↗ “To evaluate the levels of morphine in a patient's blood when morphine is given into the epidural space in the form of DepoDur® either alone or following a dose of lidocaine...” NCT00804609 ↗ “An intraoperative block of the genital branch of the genitofemoral nerve was performed in all patients in all three groups, followed by postoperative patient-controlled...” PMID 27487311 ↗ Jul 2016 “The patient is given one intrathecal dose of plain bupivacaine (Marcain® spinal) 5 mg/ml, 15 mg together with morphine (Morphine Special®) 0,4 mg/ml, 0.2 mg and clonidine...” NCT02026687 ↗ “The mixture contains 30ml (300mg) ropivacaine, 0.5ml (5 mg) morphine, 2 ml (50 mg) flurbiprofen and 0.5 ml of 1:1000 epinephrine, and then is diluted with 0.9% normal saline to...” NCT02784041 ↗ “rescue IV morphine 2-3 mg every 5-10 minutes titrated to NRS ≤ 3 for NRS ≥ 4, followed by morphine patient-controlled analgesia (1 mg bolus, 5-minute lockout, 10 mg/hour limit,...” NCT07658521 ↗ “Standard of Care analgosedation of choice using propofol, fentanyl, dexmedetomidine, morphine, hydromorphone, midazolam, or lorazepam administered according to the...” NCT06429657 ↗ “periarticular injection of 50 ml solution which contains ropivacaine 15 mg, epinephrine 0.3 mg, cefmetazole 1000mg, ketorolac 30 mg and morphine HCL 10mg before closure of...” NCT01112436 ↗ “Multimodal analgesia is administered to patients as follows : 2-3 mg of morphine (2mg if patient's weight \<60kg; 3mg if patient's weight \>60kg) + Paracetamol 1g/8h and...” NCT05673486 ↗ “Intravenous administration of paracetamol 1 g, morphine 0.1 mg/kg, dexamethasone 8 mg, and ketamine 0.5 mg/kg bolus followed by 0.3 mg/kg/h infusion for postoperative pain management.” NCT07455565 ↗ “Standard analgesia includes ketoprofen 100 mg twice daily and paracetamol 1000 mg every 8 hours for 24 hours after knee arthroplasty; morphine 10 mg IM as needed for rescue therapy.” NCT07059429 ↗ “Intrathecal 10 mg Heavy Marcaine, 200 mcg Morphine + High volume local anesthesia infiltration Bupivacaine 5mg/ml + adrenaline 5 mcg/ml 3mg/kg IBW diluted with 100cc Normal Saline” NCT03176758 ↗ “The peri-articular infiltration of multimodal agents will consist of 150 mg of levobupivacaine, 10 mg morphine and 30mg ketorolac diluted in 0.9% saline to make a volume 100 ml.” NCT01560767 ↗ “The cocktail, consists of triamcinolone 40 mg, marcaine 5 mg, and morphine 3 mg, is soaked in the gelfoam size 1x2 cm and applied on the epidura before removal of the endoscope.” NCT05738759 ↗ “experimental group (periarticular injection of bupivacaine, ketorolac, morphine, and epinephrine in saline; 80cc plus 1.3% liposomal bupivacaine 20cc; total injection 100cc).” PMID 28478185 ↗ Apr 2017 “Injection of 100 mcg of morphine, 15 mcg of fentanyl and 0.25 ml of normal salin (sterile) with 12 mg of bupivacaine in the intrathecal space to provide spinal anesthesia.” NCT05099055 ↗ “Intra-operative popliteal nerve block from the surgeon: 20mL 0.2% ropivacaine and a peri-articular injection of 10mg morphine, 30mg ketorolac and 40mg methylprednisolone.” NCT02219087 ↗ “Morphine 5 mg, ropivacaine 150 mg, tramadol 40 mg, epinephrine 1 mg, ketorolac 60 mg, and ketamine 1 g will be mixed with normal saline to prepare a total volume of 60 ml” NCT06113497 ↗ “Prior to skin closing, IV morphine 0.1 mg/kg during skin closing and automated pupillometry measurement is repeated to aim pupillary diameter is within 20% of baseline.” NCT07614607 ↗ “After obtaining return of cerebrospinal fluid, hyperbaric bupivacaine 5 mg/mL 1,5 mL (7,5 mg) and morphine 200 µg/mL, 0.5 mL (100 µg) was injected intrathecally.” NCT06860893 ↗ “At any time, if a woman experienced pain despite the prescribed treatment, the next line of treatment was MIR (morphine immediate release, 10 mg tablet).” NCT04087317 ↗ “This study tests the effectiveness of a morphine-containing gel for reducing pain caused by pressure ulcers, also known as bedsores or pressure sores.” NCT00007254 ↗ “Periarticular infiltration solution containing 400 mg Ropivicaine, 30 mg Ketorolac, 5 mg Epidural Grade Morphine, and 0.6 ml of 1:1000 Epinephrine” NCT00869037 ↗ “The remifentanil administration will be piloted by the ANI, as well as the prophylactic administration of morphine at the end of the intervention.” NCT03618082 ↗ “Injection into capsular tissue after placement of the acetabular component: 0.5% Bupivacaine 15 cc 40 mg Solumedrol 10 mg Morphine 20 cc Saline” NCT02197273 ↗ “The patient-controlled anesthesia will be filled with morphine or hydromorphone. Pumps will be programmed be on demand only with no basal rate.” NCT03393117 ↗ “In the intrathecal morphine group, 100 micrograms of morphine (0.1 mL) will be added to the 12 mg of intrathecally administered bupivacaine.” NCT06612424 ↗ “intrathecal preservative free morphine (duramorph) 200 mcg with 7.5mg of hyperbaric bupivacaine was given for a patient 18-75 years of age” NCT05257941 ↗ “Local multimodal analgesia composition will include 5mg of morphine, 500 mg of epinephrine, 15mg of ketorolac, and 20mg of bupivacaine.” NCT05019638 ↗ “The patient was informed that the intravenous bolus of rescue morphine (4mg) was available every 4 hours if the pain was intolerable.” NCT04314505 ↗ “PCA opioid will include morphine OR hydromorphone (if patient has a sensitivity or is unable to tolerate or allergic to morphine).” NCT06940570 ↗ “Intra-operatively, opioids will be titrated to heart rate and spontaneous respiration rate e.g. fentanyl, morphine, hydromorphone.” NCT03471442 ↗ “bupivacaine HCl 80 mg, morphine 4 mg, epinephrine 300 micrograms, clonidine 100 micrograms, cefuroxime 750 mg, and normal saline” NCT00492973 ↗ “The unit's protocol includes drugs such as Morphine, Hydromorphone, Fentanyl, Clonidine, Ketamine, Midazolam and Acetaminophen.” NCT04538573 ↗ “supplemented with either thoracic epidural analgesia (TE Group) or oral morphine (OM Group) for postoperative pain management” PMID 37962202 ↗ Nov 2023 “Intravenous saline or morphine will be administered at the end of surgery in intervention or control groups, respectively.” NCT01872728 ↗ “Intravenous morphine solution 0.2 mg / ml in PCA mode without basal infusion, 1mg bolus demand and lockout of 8 minutes.” NCT01961895 ↗ “Morphine PCA will be connected upon the first dose of study drug(roughly 30min prior to the completion of would suture).” NCT02811991 ↗ “Will be administered 3 ml of the investigational anesthetic in combination with morphine through the subarachnoid via.” NCT01994967 ↗ “patient is administered a PCIA with morphine boluses: 1.5-2 mg, lockout time :10 min, 1h limitation: 6-8 mg morphine.” NCT03975296 ↗ “From periarticular injection consisted of 400 mg ropivacaine, 5 mg morphine and 0.4 mg epinephrine in 50 cc solution.” NCT06557018 ↗ “classic anesthetic strategy with postoperative analgesia associating Paracetamol and Morphine with standardized dose.” NCT07149077 ↗ “10mg morphine in 5ml normal saline + 10ml of 0.25% bupivacaine ( total volume 15 ml) were injected intra-articularly” NCT04790292 ↗ “Epidural analgesia was continued for next 24 hours with a mixture of ropivacaine 2.2 mg/ml and morphine 0.4 mg/ml.” NCT04587505 ↗ “0.1 microgram morphine (IV) and diclofenac sodium 75 mg intramuscularly will perform for postoperative analgesia.” NCT04148729 ↗ “Intraoperative opioids (Fentanyl or Morphine) will be administered as deemed necessary by anesthesia care team.” NCT01500109 ↗ “Repeat doses of pain medication will be given as 0.05 mg/kg morphine or equivalent dose of opioid analgesic.” NCT02489630 ↗ “Intravenous morphine sulfate (0.05mg/kg) was given as a rescue medication if the VAS ≥ 4 for both groups.” NCT04482192 ↗ “Subjects with intolerance to oxycodone will receive the equivalent dosing of morphine as an alternative.” NCT06837857 ↗ “This arm is composed of Remifentanil hydrochloride and postoperative rescue analgesia will be morphine.” NCT05887258 ↗ “low-dose morphine (or an alternative opioid if allergic to morphine) at 0.025 mg/kg/dose every 4 hours.” NCT04291599 ↗ “3 nebulisations of 5 mg morphine chlorhydrate each given over 30 minutes (10 minutes per nebulisation)” NCT02156596 ↗ “IV morphine patient controlled analgesia (PCA) is being used in the postoperative period for 48 hours.” NCT02302586 ↗ “add Nefopam 30 mg ×3/day for moderate pain; morphine (Actiskenan) 5-10 mg every 4-6 h for severe pain” NCT07414706 ↗ “Both 2.5 µg sufentanil and 100 µg morphine were added to the local anaesthetic agent in both groups.” PMID 33428221 ↗ Jan 2021 “Patients in both groups will have PCA dilaudid or morphine prescribed for the post-operative period.” NCT03458598 ↗ “After methylnaltrexone or placebo administration, all patients received morphine (5 mg intravenous).” PMID 31377269 ↗ Jul 2019 “Postoperative analgesia was administered through a morphine the patient-controlled analgesia device.” NCT02645903 ↗ “conventional pain medications including narcotics (like morphine, etc.) and sedatives (like valium)” NCT02044302 ↗ “Parenteral morphine administered by bolus or patient-controlled analgesia to maintain pain control.” NCT01932554 ↗ “Hydromorphone Patient Controlled Analgesia (PCA),Preservative free Morphine via epidural for 36hrs” NCT06617949 ↗ “This classic patient-controlled IV-pump contains 1mg/ml morphine and 50mcg/ml dehydrobenzperidol.” NCT03036514 ↗ “The injection contained 150mg bupivacaine (3mg/mL), 60mg ketorolac(1.2mg/mL) and 1mg morphine.” NCT06630520 ↗ “Intravenous patient controlled analgesia with morphine(1mg/ml)for post operative pain control” NCT01929915 ↗ “Combination of paracetamol + non-steroidal anti-inflammatory drug + morphine to all patients” NCT03639389 ↗ “Intravenous patient controlled analgesia with morphine 1mg/ml for postoperative pain control” NCT04079673 ↗ “Morphine (MO) is the most commonly used opioid for the treatment of post-surgical pain (14).” NCT00849719 ↗ “Oral Opioids (Codeine, Tramadol, Hydrocodone, Oxycodone, Methadone, Morphine, Hydromorphone)” NCT03472469 ↗ “iv morphine with patient controlled analgesia (1 mg demand bolus dose, 20 min lockout time)” NCT02778958 ↗ “Morphine analgesia controlled by the patient will begin 2 hours after tracheal extubation” NCT05322603 ↗ “A mixture of 5% ketamine and 5% morphine will be prepared in a 100 cc bag of 0.9% saline.” NCT06774274 ↗ “5mg morphine, 500 micrograms epinephrine, and 4ml normal saline (superficial injection).” NCT05037812 ↗ “morphine (administered intravenously at a dosage of 2-4 mg, up to a maximum dose of 8 mg” NCT06653244 ↗ “followed by morphine 0.05 mg/kg ABW after intubation and nasal decongestant application” NCT07299630 ↗ “Standardized spinal mixture of 10.25 mg hyperbaric bupivacaine, and 0.125 mg morphine.” NCT06418308 ↗ “Patients allocated to this group receive a combination of Morphine and Dexmedetomidine” NCT03936205 ↗ “isobaric bupivacaine 0.5% 10 mg together with preservative-free morphine was injected.” NCT01477190 ↗ “Morphine 0.1 mg/kg PRN will be administered every 8 hours for postoperative analgesia” NCT04648540 ↗ “IV-PCA programmed with morphine boluses of 2-3 mg and a lock-out time of 5-15 minutes” NCT01541137 ↗ “The intravenous injection of morphine using the patient-controlled analgesia machine” NCT01991275 ↗ “For patients with a FLACC score of 6-10, morphine (0.05mg/kg) will be administered.” NCT03467750 ↗ “Patients will receive IV morphine 0.1mg/kg after induction of general anesthesia.” NCT06584695 ↗ “use of IV propofol for sedation and morphine, the drug of choice for cardiac pain” NCT02546765 ↗ “* Morphine 7.5 mg by mouth every four to six hours as needed for pain, 10 doses” NCT05722002 ↗ “Drug: Morphine will be injected in the subarachnoid space with a dose of 100 μg” NCT03849508 ↗ “with morphine 250mic and atropine sulphate 100 micwith total volume = 2.5 ml” NCT05137288 ↗ “400 mg Ropivacaine, 5 mg morphine, and 0.4 mg epinephrine in 100 cc solution” NCT02369523 ↗ “In Morphine group, patients will receive morphine as needed after surgery.” NCT03854851 ↗ “One group will receive bupivacaine 15 mg and morphine 100 ug intrathecally” NCT05406765 ↗ “Postoperative morphine 0.03 mgr / kgr / weight was administered if EVA ≥4” NCT02239497 ↗ “Group treated with intravenous Patient-Controlled Analgesia with Morphine” NCT05259098 ↗ “Bupivacaine 0.25% + midazolam 5mg and morphine 5mg in total volume 10ml” NCT04033471 ↗ “Opioids: heroin, morphine, oxycodone, hydrocodone, methadone, codeine” NCT02033707 ↗ “IV Ketamine 0.1 mg/kg with IV morphine -0.1 mg/kg with IM Sailne 0.9%” NCT04013958 ↗ “Receive Morphine Patient Controlled Analgesia + NSAIDs + Paracetamol” NCT06750627 ↗ “positive result 10μg/kg morphine; negative result 50μg/kg morphine.” NCT02990910 ↗ “* IV Morphine (or Dilaudid): 1 or 2 mg q 2hr prn breakthrough pain” NCT02219581 ↗ “morphine given by PCA (patient-controlled analgesia) at 1 mg/dose” NCT05069311 ↗ “Morphine every 4 hours as needed for up to a maximum of 5 days” NCT03429400 ↗ “IV morphine-PCA will be applied postoperatively for 24 hours .” NCT06630858 ↗ “Morphine (Apokyn®, Avinza®, Kadian®, MS-Contin®, among others)” NCT06240390 ↗ “Intrathecal spinal morphine (5 mcg / kg) immediately post-op” NCT03537612 ↗ “Intrathécale morphine is used for post-cesarean pain control” NCT01211431 ↗ “morphine 150 mcg will be used by intrathecal administration” NCT04814745 ↗ “Morphine 0.1-0.12mg/kg, Fentanyl 1-2mcg/kg during induction” NCT04894864 ↗ “1 ml morphine sulfate 10 mg/ml (DarouPakhsh, Tehran, Iran)” NCT05324995 ↗ “A base low dose opioid of 5mg morphine I.V every 8 hours.” NCT03193658 ↗ “Morphine medications are the mainstay of pain management” NCT05515809 ↗ “using ropivacaine, epinephrine, ketorolac, and morphine” PMID 24706022 ↗ Jan 2015 “In case of opioid use, morphine treatment is preferred.” NCT04745520 ↗ “patient-controlled intravenous analgesia with morphine” PMID 28178436 ↗ Jan 2017 “Continuous morphine/midazolam and 'as needed' doses.” NCT02112448 ↗ “IV analgesia, typically Morphine/Opioid medications” NCT04892563 ↗ “Examples of opioids are morphine and hydromorphone.” NCT04221165 ↗ “bolus dose 2,5 mg i.v. morphine, 15 minutes lockout” NCT02576223 ↗ “Morphine, oxycodone, metadone, fentanyl, tramadol” NCT03365817 ↗ “Intravenous analgesia is performed with morphine.” NCT03012945 ↗ “with tramadol and/or morphine provided as rescue.” NCT07337135 ↗ “Post-operative morphine IV for breakthrough pain” NCT06935331 ↗ “IV paracetamol 1 g/6 h + IV PCA morphine rescue” PMID 28192892 ↗ Feb 2017 “Rescue opioids if VAS\>4: Adolonta or Morphine” NCT07558226 ↗ “0.1 mg/kg morphine intravenous pre operative” NCT06935006 ↗ “Patients will receive morphine 0.1 mg/kg” NCT04402411 ↗ “morphine 0.1 mg/kg IV every six hours” NCT05393414 ↗ “morphine sulphate sustained release” NCT04132011 ↗ “Intravenous morphine bolus of 3 mg” NCT00874172 ↗ “Desflurane, Morphine, Paracetamol” NCT05172739 ↗ “slow-release oral morphine (SROM)” NCT01079117 ↗ “100 µ of intrathecal Morphine” NCT02711072 ↗ “Morphine Sulfate0.1 Mg/Kg Iv” NCT01465984 ↗ “5 mg morphine intravenously” NCT02627950 ↗ “Epidural morphine 4mg bolus” NCT00848419 ↗ “intrathecal morphine 100mcg” NCT03518463 ↗ “Intrathecal morphine (ITM)” NCT03261193 ↗ “ITM (Intrathecal Morphine)” NCT06666985 ↗ “Morphine, Pain intensity” NCT01541124 ↗ “Epidural Morphine 150ug” NCT01511627 ↗ “Midazolam and morphine” NCT00416039 ↗ “intranasal morphine” NCT00474799 ↗ “0.1 mg/kg morphine” NCT05752799 ↗ “Morphine 1 mg/ml” NCT01367418 ↗ “Morphine Sulfate” NCT07296770 ↗ “PCA, morphine” NCT00880529 ↗ “morphine” NCT04234516 ↗ “Morphine” NCT02785003 ↗ “morphine” NCT05463367 ↗ “Morphine” NCT02132416 ↗ “morphine” NCT01705288 ↗ “Morphine” NCT02886286 ↗ |
| Known as | Actiskenan | “morphine (Actiskenan) 5-10 mg every 4-6 h for severe pain” NCT07414706 ↗ |
| Known as | Apokyn | “Morphine (Apokyn®, Avinza®, Kadian®, MS-Contin®, among others)” NCT06240390 ↗ |
| Known as | Avinza | “We would like to learn if a medicine called "modified-release morphine sulfate" (Avinza) helps reduce Spinal Cord Injury (SCI)-related pain that has lasted a long time.” NCT00488969 ↗2“Morphine (Apokyn®, Avinza®, Kadian®, MS-Contin®, among others)” NCT06240390 ↗ “Avinza (morphine sulfate sustained-release) capsules” NCT00782548 ↗ |
| Known as | Chlorhydrate of Morphine | “Doses of 1 mg of Chlorhydrate of Morphine will be delivered intravenously by the Patient Controlled Analgesia (PCA) pump.” NCT02292667 ↗ |
| Known as | DepoDur | “The primary purpose of this study is to evaluate the effects of lidocaine/epinephrine test dose administration on the PK profile of a single epidural dose of DepoDur...” NCT00728832 ↗ |
| Known as | Depolan | “Depolan (morphine), Ebixa (memantine)” NCT02467556 ↗ |
| Known as | Dimorf | “Dimorf” NCT05800834 ↗ |
| Known as | Duramorph | “Intrathecal preservative free morphine (duramorph) 200 mcg with 7.5mg of hyperbaric bupivacaine placed by a spinal needle prior to induction of general anesthesia (n=71)” NCT06593665 ↗8“Multimodal local injection of bupivacaine (Marcaine), morphine sulfate (Duramorph), ketorolac (Toradol) given at the fracture site at the time of hip fracture surgery” PMID 37199438 ↗ Sep 2023 “intrathecal preservative free morphine (duramorph) 200 mcg with 7.5mg of hyperbaric bupivacaine was given for a patient 18-75 years of age” NCT05257941 ↗ “preservative free morphine (Duramorph)” NCT05506930 ↗ |
| Known as | Egalet morphine | “Egalet® morphine, Controlled Release 30 mg Oral tablet once daily for 2 weeks and MST Continus® 15 mg twice daily for 2 weeks” NCT00446069 ↗1“Single dose administration of Egalet® morphine with alcohol” NCT00802308 ↗ |
| Known as | EREM | “The primary objective was to evaluate the serum pharmacokinetic profile of a single 15-mg dose of extended-release epidural morphine (EREM) administered at the lower thoracic...” PMID 19840530 ↗ Nov 20092“Extended-release Epidural morphine (EREM) 80” NCT00955877 ↗ “Extended Release Epidural Morphine (EREM)” NCT00934661 ↗ |
| Known as | Immediate release morphine | “Immediate release morphine, solution Dosage: Start with a minimum of 5mg (to be determined by titration)” NCT04635852 ↗ |
| Known as | intra spinal morphine | “intra spinal morphine” NCT00695045 ↗ |
| Known as | Intrathecal morphine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01312077 ↗ |
| Known as | IRM | “immediate-release morphine (IRM) as solution or tablet is most frequently used in clinical practice to treat episodic breathlessness.” NCT04635852 ↗ |
| Known as | ITM | “This randomized double-blind trial investigates the relative contributions of adductor canal block and low-dose intrathecal morphine (ITM) to postoperative analgesia and...” PMID 29315129 ↗ Feb 20186“Intrathecal morphine (ITM) and continuous wound infiltration (CWI) are two alternatives to thoracic epidural analgesia in major abdominal surgery” PMID 42403225 ↗ Jul 2026 “Erector Spinae Plane Block (ESPB) and intrathecal morphine (ITM) provide adequate postoperative (PO) analgesia.” PMID 40047853 ↗ Mar 2025 “120 mcg intrathecal morphine (ITM) will be administered to the morphine group.” NCT06076018 ↗ “Intrathecal morphine sulfate (ITM)” NCT04368364 ↗ “Intrathecal morphine (ITM)” NCT03261193 ↗ “ITM (Intrathecal Morphine)” NCT06666985 ↗ |
| Known as | IVMS | “IVMS (IV Morphine)” NCT01904071 ↗ |
| Known as | KADIAN | “a test formulation of morphine sulfate 200 mg sustained-release capsules manufactured by Alpharma Branded Products Division Inc. to an equivalent oral dose of the commercially...” NCT00759356 ↗5“Morphine (Apokyn®, Avinza®, Kadian®, MS-Contin®, among others)” NCT06240390 ↗ “KADIAN (morphine sulfate sustained-release) capsules” NCT00782548 ↗ “KADIAN (morphine sulfate sustained-release) capsules” NCT00759954 ↗ “KADIAN (morphine sulfate extended-release) capsules” NCT00759915 ↗ “KADIAN (morphine sulfate extended-release) capsules” NCT00759902 ↗ |
| Known as | MIR | “At any time, if a woman experienced pain despite the prescribed treatment, the next line of treatment was MIR (morphine immediate release, 10 mg tablet).” NCT04087317 ↗ |
| Known as | MNS075 | “Intranasal (IN) Morphine Nasal Spray (MNS075) 7.5 mg and 15 mg” NCT00390039 ↗ |
| Known as | MOR | “Patients were consented and randomized to receive, either IV ketamine (LDK) 1 mg/kg or IV morphine (MOR) 0.1 mg/kg as an infusion over 10 min.” PMID 29794277 ↗ Jan 2018 |
| Known as | Morfin | “spinal injection of 12 mg bupivacain,160 ug morfin och klonidin, according to age” NCT02030717 ↗ |
| Known as | Morfina cloridrato 10 mg /ml - Morphine | “Morfina cloridrato 10 mg /ml - Morphine” NCT01249872 ↗ |
| Known as | Morfini Sulfas WZF | “postoperative rescue opioid analgesia will be administered intravenously using 2 miligrams of morphine ((Morfini Sulfas WZF, 20mg/ml, solutio pro iniectione, Polfa Warszawa, Poland)” NCT06609993 ↗ |
| Known as | Morphin | “morphine hydrochloride (morphine hydrochloride 2 mg/ml, Morphin® Nycomed Austria GmbH, St. Peter Strasse 25, A-4021, Linz, Austria)” NCT01084473 ↗1“Morphin” NCT00878293 ↗ |
| Known as | Morphine (intrathecal) | “Morphine (intrathecal)” NCT07584200 ↗ |
| Known as | Morphine = morphine | “Morphine = morphine” NCT01367418 ↗ |
| Known as | morphine chlorhydrate | “Morphine was previously prepared by a study nurse by diluting a 10 mg / 1 ml flakon of morphine chlorhydrate in a 9 ml solution of serum saline to obtain a 10 ml preparation (1...” NCT02781415 ↗1“inhaled titration of morphine chlorhydrate” NCT03257319 ↗ |
| Known as | Morphine Chloride | “Drug: Morphine Chloride” NCT04700007 ↗ |
| Known as | Morphine HCl | “Pre-induction intrathecal morphine HCl (\< 3 attempts), single shot via 25 G pencil point spinal needle at 10 micrograms/kilogram” NCT00553553 ↗1“Drug: Morphine HCl” NCT04582786 ↗ |
| Known as | Morphine hydrochloride | “Morphine hydrochloride injection (80mg) plus 0.9% saline are combined into 80 ml self-controlled analgesic pump, which will be run 25minutes before ablation under...” NCT05073744 ↗14“The auxiliary drug on which both experimental strategies are based is MORPHINE: Morphine hydrochloride AGUETTANT 0.1 mg/mL Solution for injection (ready-to-use ampoule) for...” NCT07076641 ↗ “Morphine solution (0.1mg/ml, Morphine Hydrochloride) 50 μl will be applied intradermally to the center of a predetermined area on the volar forearm by a 1 ml syringe.” NCT04700007 ↗ “morphine hydrochloride (morphine hydrochloride 2 mg/ml, Morphin® Nycomed Austria GmbH, St. Peter Strasse 25, A-4021, Linz, Austria)” NCT01084473 ↗ “Drug: Morphine Hydrochloride Morphine hydrochloride injection is used for perioperative lung tumor ablation” NCT05848635 ↗ “a bolus of 150 mcg / Kg of morphine hydrochloride, approximately 60 minutes before extubation” NCT02571491 ↗ “Patients are receiving Morphine hydrochloride under thoracic surgery” NCT06172920 ↗ “5 mg of morphine hydrochloride (10mg/ml Braun Medical SA Spain)” NCT05248724 ↗ “Morphine hydrochloride, remifentanil hydrochloride” NCT00553553 ↗ “Morphine hydrochloride, Spinal” NCT03434951 ↗ “Drug: Morphine hydrochloride” NCT04427826 ↗ “Morphine hydrochloride,” NCT02173756 ↗ |
| Known as | Morphine Hydrochloride Injection | “The pump is filled with a 100 mL mixture of the active comparator drug, Morphine Hydrochloride Injection, at a concentration of 0.25 mg/mL, and the same adjuvant drug,...” NCT07412223 ↗ |
| Known as | Morphine hydrochloride oral solution 2 mg/ml | “Morphine hydrochloride oral solution 2 mg/ml” NCT01245244 ↗ |
| Known as | Morphine Kalceks | “In Spinal group, 25 G or 27 G pencil point needle, depending on the preference of the anesthesiologist, will be inserted at L2-L3 or L3-L4 intervertebral space and 300 μg of...” NCT06935708 ↗1“300 μg of preservative-free morphine (Morphine Kalceks ®, Kalceks, AS, Riga, Latvija, 10mg/ml) diluted with sterile saline to a volume of 3 mL will be injected intrathecally.” NCT06881563 ↗ |
| Known as | Morphine Special | “The patient is given one intrathecal dose of plain bupivacaine (Marcain® spinal) 5 mg/ml, 15 mg together with morphine (Morphine Special®) 0,4 mg/ml, 0.2 mg and clonidine...” NCT02026687 ↗1“Morphine special (preservative-free) injected intrathecally” NCT01281891 ↗ |
| Known as | morphine SR | “In one-third of the patients oral sustained release morphine (morphine SR) doesn't relieve dyspnea” NCT02429050 ↗ |
| Known as | morphine sulfate | “AVINZA (morphine sulfate extended-release capsules) was approved for marketing by the Food and Drug Administration (FDA) in 2002 as a once daily treatment for the relief of...” NCT00640042 ↗100“To compare the effect of prophylactic fentanyl buccal tablet (FBT), morphine sulfate, and placebo on the increase in the intensity of exertional dyspnea (0-10 point modified...” NCT04188418 ↗ “A Study to Evaluate the Effects of Epidural Lidocaine Administration on the Pharmacokinetic and Pharmacodynamic Profiles of DepoDur® (Morphine Sulfate Extended-release...” NCT00804609 ↗ “Safety and pharmacokinetics of an abuse-deterrent, extended-release formulation of morphine sulfate with a sequestered naltrexone core in children 7-17 with moderate-severe pain.” NCT02101554 ↗ “A long acting comparator (slow-release morphine sulfate 45 mg) will be chosen because of its putative equianalgesic effects to the dose of hydrocodone (30 mg) selected.” NCT00314340 ↗ “Multimodal local injection of bupivacaine (Marcaine), morphine sulfate (Duramorph), ketorolac (Toradol) given at the fracture site at the time of hip fracture surgery” PMID 37199438 ↗ Sep 2023 “patients will be received morphine sulfate (0.02 mg/kg) bolus doses were used to preserve MAP and HR within 20% of pre-induction readings” NCT04859803 ↗ “comparing ketamine hydrochloride (20 mg, followed by 10 mg every 5 minutes) with morphine sulfate (2 or 3 mg every 5 minutes)” PMID 38285446 ↗ Jan 2024 “morphine sulfate 30 mg tablet, morphine sulfate 15 mg tablet, morphine sulfate controlled release 120 mg” NCT00994383 ↗ “standardized intravenous (IV) morphine sulfate or Sponsor-approved equivalent for postsurgical analgesia” NCT01509638 ↗ “200 µg morphine sulfate, single-dose via L3-L4, 27G Sprotte spinal needle, prior to induction.” NCT07231926 ↗ “Group I: (n=20) received IV 0.1mg/kg morphine sulphate (morphine sulfate ®, Misr CO Pharma).” NCT02449954 ↗ “over-encapsulated Morphine Sulfate prolonged release 5mg tablet, twice daily for 14 days.” NCT04429516 ↗ “Epidural bolus of 4mg of preservative free morphine sulfate (4mL of 1mg/mL solution)” NCT03525509 ↗ “single IV dose of morphine sulfate 0.12 mg/kg after dental impaction surgery” NCT00782951 ↗ “1 ml morphine sulfate 10 mg/ml (DarouPakhsh, Tehran, Iran)” NCT05324995 ↗ “* Morphine Sulfate (MS) Contin: Use as backup prn pain” NCT02219581 ↗ “morphine sulfate and naltrexone hydrochloride (EMBEDA)” NCT01179191 ↗ “intranasal Fentanyl vs morphine sulfate (oral use)” NCT03063359 ↗ “Drug: morphine sulfate extended-release capsules” NCT00759902 ↗ “MS Contin (morphine sulfate, controlled release)” NCT01380093 ↗ “Immediate-release Oral Morphine Sulfate Tablets” NCT04030442 ↗ “Level 3: Oxycodone 5mg, Morphine sulfate 10mg.” NCT04330547 ↗ “morphine sulfate sustained-release capsules” NCT00759954 ↗ “Morphine Sulfate from Darupakhsh Company” NCT05630222 ↗ “Intrathecal morphine sulfate (ITM)” NCT04368364 ↗ “immediate release morphine sulfate” NCT00751478 ↗ “morphine sulfate 5 mL(5 mg)” NCT01898052 ↗ “Drug: Morphine Sulfate” NCT05069012 ↗ “Drug: Morphine Sulfate” NCT03437707 ↗ “Drug: Morphine Sulfate” NCT02962024 ↗ “Drug: Morphine Sulfate” NCT05251376 ↗ “Drug: Morphine Sulfate” NCT04772222 ↗ “Drug: morphine sulfate” NCT00726830 ↗ “Drug: Morphine Sulfate” NCT05186454 ↗ “Drug: Morphine Sulfate” NCT00839787 ↗ “Morphine Sulfate 30 mg” NCT04234516 ↗ “Drug: Morphine Sulfate” NCT03024957 ↗ “Morphine sulfate 12 mg” NCT01016808 ↗ “Drug: Morphine Sulfate” NCT07054775 ↗ “2 mg morphine sulfate” NCT05582135 ↗ “Morphine sulfate” NCT03682211 ↗ “Morphine Sulfate” NCT00822614 ↗ |
| Known as | Morphine sulfate (MS) Contin, Astramorph, Depodur, Duramorph, Infumorph, Kadian, MorphaBond, Arymo ER (morphine) | “Morphine sulfate (MS) Contin, Astramorph, Depodur, Duramorph, Infumorph, Kadian, MorphaBond, Arymo ER (morphine)” NCT05037812 ↗ |
| Known as | morphine sulfate extended-release liposome injection | “morphine sulfate extended-release liposome injection” NCT00895531 ↗ |
| Known as | Morphine Sulfate Injection USP | “Morphine Sulfate Injection USP” NCT05324358 ↗ |
| Known as | Morphine sulphate | “Patients will receive a single intravenous (IV) infusion administered over 3 minutes of either ORG 28611 (SCH 900111), 0.12 mg/kg morphine sulphate, or placebo” NCT00782951 ↗15“PAciFy Cough is a multicenter, double-blind, placebo-controlled, crossover trial of morphine sulphate for the treatment of cough in IPF.” PMID 35236391 ↗ Mar 2022 “30 patients received morphine in a dose of 10-50μg/ kg/hr as an analgesic (Morphine Sulphate ampoule; 10 mg/ 1ml, Misr Co.- Egypt)” NCT03078946 ↗ “Morphine group (GM): given ultrasound guided TAP-block with 20ml 0.5% bupivacaine+10mg morphine sulphate diluted in 20ml saline” PMID 28494906 ↗ Mar 2017 “Group I: (n=20) received IV 0.1mg/kg morphine sulphate (morphine sulfate ®, Misr CO Pharma).” NCT02449954 ↗ “tramadol hydrochloride 100 mg three times daily , morphine sulphate 30 mg twice daily” NCT04589494 ↗ “0.125% bupivacaine HCL + Morphine sulphate 3 mg” NCT01838707 ↗ “Morphine Sulphate Controlled Release” NCT00472303 ↗ “Drug: Morphine sulphate” NCT00802308 ↗ “Drug: Morphine sulphate” NCT03682211 ↗ “Drug: Morphine sulphate” NCT00553553 ↗ |
| Known as | Morphine sulphate 10mg/ml, Martindale Pharmaceuticals (UK) | “Morphine sulphate 10mg/ml, Martindale Pharmaceuticals (UK)” NCT02434939 ↗ |
| Known as | Morphine, Orion (ATC code: N02A A01) | “Morphine, Orion (ATC code: N02A A01)” NCT05639712 ↗ |
| Known as | MS Contin, Astramorph, Depodur, Duramorph, Infumorph, Kadian, MorphaBond, Arymo ER (morphine) | “MS Contin, Astramorph, Depodur, Duramorph, Infumorph, Kadian, MorphaBond, Arymo ER (morphine)” NCT05019638 ↗ |
| Known as | MS-Contin | “This study will test the effectiveness of two drugs-nortriptyline and MS Contin (a type of morphine)-to treat pain caused by lumbar radiculopathy, or sciatica.” NCT00009672 ↗4“Morphine (Apokyn®, Avinza®, Kadian®, MS-Contin®, among others)” NCT06240390 ↗ “* Morphine Sulfate (MS) Contin: Use as backup prn pain” NCT02219581 ↗ “MS Contin (morphine sulfate, controlled release)” NCT01380093 ↗ |
| Known as | MSIR | “Oxycodone or morphine sulfate immediate release (MSIR)” NCT02824276 ↗1“Morphine Sulfate Immediate Release (MSIR)” NCT00751478 ↗ |
| Known as | MST | “low dose (5mg) controlled release Morphine sulfate (MST) will reduce the number of coughs recorded during a 24hr period in patients with IPF.” NCT04429516 ↗ |
| Known as | MST Continus | “Egalet® morphine, Controlled Release 30 mg Oral tablet once daily for 2 weeks and MST Continus® 15 mg twice daily for 2 weeks” NCT00446069 ↗ |
| Known as | nMOR | “OBJECTIVE: To determine the predictive factors of nebulized morphine (nMOR)” PMID 36196899 ↗ Oct 2022 |
| Known as | Opioid Analgesic | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06202664 ↗ |
| Known as | Opioids | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03023982 ↗ |
| Known as | Oxycotin | “Oxycotin” NCT02094807 ↗ |
| Known as | PFMS | “The pharmacological agent used in the pump for this study is limited to a preservative-free morphine sulfate (PFMS).” NCT03761277 ↗ |
| Known as | spinal morphine | “spinal morphine” NCT03428880 ↗ |
| Known as | SROM | “slow-release oral morphine (SROM)” NCT01079117 ↗ |
| Known as | Sterop | “During the first 24 postoperative hours, analgesia will be provided via a patient-controlled analgesia (PCA) pump delivering 2 mg intravenous HCL morphine (Sterop®) boluses on demand.” NCT07568405 ↗ |
| Known as | sulfate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02124447 ↗ |
| Known as | Suprep | “4. Split dose sodium sulfate, magnesium sulfate, and potassium sulfate solution (sulfate): Brand name Suprep” NCT02124447 ↗ |
| Action | Activate | “This effect is based on an activation of peripheral opioid receptors” NCT00244153 ↗ |
| Modality | Other / unclassified | “Fentanyl HCl and morphine are narcotic pain relievers.” NCT00264485 ↗ |
| Route | Intravenous | “The current double-blind, placebo-controlled in-patient study was designed to compare the effects of intravenously delivered fentanyl (0, 0.0625, 0.125, 0.187, and 0.250 mg/70...” PMID 17581533 ↗ Jun 2007 |
| Target | OPRM1 | “The mu-opioid receptor (OPRM1 gene)is the site of action of endogenous opioid peptides and opioid analgesic drugs like morphine.” NCT01465191 ↗ |